SIMILAR PATTERNS OF AMINO ACIDS FOR 4Q5M_A_ROCA1101
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1agx | GLUTAMINASE-ASPARAGINASE (Acinetobacterglutaminasificans) |
PF00710(Asparaginase) | 5 | GLY A 51ILE A 13ILE A 88VAL A 74ILE A 112 | None | 0.88A | 4q5mA-1agxA:undetectable | 4q5mA-1agxA:19.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1guz | MALATE DEHYDROGENASE (Chlorobaculumtepidum;Prosthecochlorisvibrioformis) |
PF00056(Ldh_1_N)PF02866(Ldh_1_C) | 5 | GLY A 141ILE A 74THR A 102ILE A 3THR A 15 | None | 1.03A | 4q5mA-1guzA:undetectable | 4q5mA-1guzA:23.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 11 | GLY A 27ASP A 29ILE A 47ILE A 50THR A 80PRO A 81VAL A 82ARG A 8VAL A 32ILE A 47THR A 80 | A79 A 800 (-3.0A)A79 A 800 (-2.7A)A79 A 800 ( 3.4A)A79 A 800 ( 4.0A)NoneA79 A 800 ( 3.4A)A79 A 800 (-4.5A)A79 A 800 (-3.4A)A79 A 800 ( 4.4A)A79 A 800 ( 3.2A)None | 0.53A | 4q5mA-1hvcA:33.5 | 4q5mA-1hvcA:95.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 11 | GLY A 27ASP A 29ILE A 47ILE A 50THR A 80PRO A 81VAL A 82ARG A 8VAL A 32ILE A 47THR A 80 | A79 A 800 (-3.0A)A79 A 800 (-2.8A)A79 A 800 ( 3.2A)A79 A 800 (-3.8A)NoneA79 A 800 ( 3.9A)A79 A 800 (-4.5A)A79 A 800 (-3.6A)A79 A 800 ( 4.3A)A79 A 800 ( 3.4A)None | 0.62A | 4q5mA-1hvcA:33.5 | 4q5mA-1hvcA:95.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1l1j | HEAT SHOCK PROTEASEHTRA (Thermotogamaritima) |
PF13365(Trypsin_2) | 5 | GLY A 207ASP A 127ILE A 131VAL A 107ILE A 133 | None | 0.98A | 4q5mA-1l1jA:undetectable | 4q5mA-1l1jA:24.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1mpo | MALTOPORIN (Escherichiacoli) |
PF02264(LamB) | 5 | GLY A 190ASP A 173THR A 236ARG A 175ILE A 272 | None | 0.98A | 4q5mA-1mpoA:undetectable | 4q5mA-1mpoA:17.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1muu | GDP-MANNOSE6-DEHYDROGENASE (Pseudomonasaeruginosa) |
PF00984(UDPG_MGDP_dh)PF03720(UDPG_MGDP_dh_C)PF03721(UDPG_MGDP_dh_N) | 5 | GLY A 12ILE A 27ILE A 82VAL A 31ILE A 99 | NoneNoneNoneNAD A1001 (-4.4A)None | 1.01A | 4q5mA-1muuA:undetectable | 4q5mA-1muuA:20.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1nbw | GLYCEROL DEHYDRATASEREACTIVASE ALPHASUBUNIT (Klebsiellapneumoniae) |
PF08841(DDR) | 5 | GLY A 170ASP A 168ILE A 164VAL A 201ILE A 134 | None | 0.90A | 4q5mA-1nbwA:undetectable | 4q5mA-1nbwA:18.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1o4z | BETA-AGARASE B (Zobelliagalactanivorans) |
PF00722(Glyco_hydro_16) | 6 | GLY A 248ILE A 63ILE A 347VAL A 342VAL A 153ILE A 80 | None | 1.49A | 4q5mA-1o4zA:undetectable | 4q5mA-1o4zA:19.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1q9j | POLYKETIDE SYNTHASEASSOCIATED PROTEIN 5 (Mycobacteriumtuberculosis) |
PF00668(Condensation)PF16911(PapA_C) | 5 | GLY A 114ILE A 28THR A 355PRO A 356ARG A 112 | None | 1.02A | 4q5mA-1q9jA:undetectable | 4q5mA-1q9jA:19.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1qso | HPA2 HISTONEACETYLTRANSFERASE (Saccharomycescerevisiae) |
PF00583(Acetyltransf_1) | 5 | ASP A 18ILE A 73ARG A 12VAL A 112ILE A 90 | None | 1.01A | 4q5mA-1qsoA:undetectable | 4q5mA-1qsoA:23.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1siv | SIV PROTEASE (Simianimmunodeficiencyvirus) |
PF00077(RVP) | 5 | GLY A 27ASP A 29ILE A 50THR A 80PRO A 81 | None | 0.37A | 4q5mA-1sivA:15.6 | 4q5mA-1sivA:28.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1wdw | TRYPTOPHAN SYNTHASEALPHA CHAINTRYPTOPHAN SYNTHASEBETA CHAIN 1 (Pyrococcusfuriosus) |
PF00290(Trp_syntA)PF00291(PALP) | 5 | GLY B 276ILE B 289VAL B 271VAL A 114ILE A 92 | None | 0.92A | 4q5mA-1wdwB:undetectable | 4q5mA-1wdwB:22.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1xc6 | BETA-GALACTOSIDASE (Penicillium sp.) |
PF01301(Glyco_hydro_35)PF10435(BetaGal_dom2)PF13363(BetaGal_dom3)PF13364(BetaGal_dom4_5) | 5 | GLY A 860ASN A 353ILE A 800VAL A 798ILE A 822 | None | 1.04A | 4q5mA-1xc6A:undetectable | 4q5mA-1xc6A:11.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1xhb | POLYPEPTIDEN-ACETYLGALACTOSAMINYLTRANSFERASE 1 (Mus musculus) |
PF00535(Glycos_transf_2)PF00652(Ricin_B_lectin) | 5 | GLY A 217ILE A 237PRO A 285ILE A 226THR A 206 | None | 1.04A | 4q5mA-1xhbA:undetectable | 4q5mA-1xhbA:19.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1yzf | LIPASE/ACYLHYDROLASE (Enterococcusfaecalis) |
PF13472(Lipase_GDSL_2) | 5 | ASP A 79ILE A 128ILE A 110VAL A 72ILE A 182 | None | 1.01A | 4q5mA-1yzfA:undetectable | 4q5mA-1yzfA:23.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1zpu | IRON TRANSPORTMULTICOPPER OXIDASEFET3 (Saccharomycescerevisiae) |
PF00394(Cu-oxidase)PF07731(Cu-oxidase_2)PF07732(Cu-oxidase_3) | 5 | ASP A 146ILE A 142THR A 240VAL A 234THR A 58 | NoneNAG A2002 ( 4.8A)NoneNoneMAN A3008 ( 4.5A) | 0.87A | 4q5mA-1zpuA:undetectable | 4q5mA-1zpuA:15.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1zuw | GLUTAMATE RACEMASE 1 (Bacillussubtilis) |
PF01177(Asp_Glu_race) | 5 | ASP A 163ILE A 165ARG A 197VAL A 203ILE A 178 | None | 0.94A | 4q5mA-1zuwA:undetectable | 4q5mA-1zuwA:24.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2a4a | DEOXYRIBOSE-PHOSPHATE ALDOLASE (Plasmodiumyoelii) |
PF01791(DeoC) | 5 | GLY A 82ILE A 144VAL A 162ILE A 170THR A 158 | None | 1.01A | 4q5mA-2a4aA:undetectable | 4q5mA-2a4aA:20.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2acv | TRITERPENEUDP-GLUCOSYLTRANSFERASE UGT71G1 (Medicagotruncatula) |
PF00201(UDPGT) | 5 | GLY A 178ASN A 181PRO A 189VAL A 217THR A 219 | None | 1.03A | 4q5mA-2acvA:undetectable | 4q5mA-2acvA:22.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ani | RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASEBETA SUBUNIT (Chlamydiatrachomatis) |
PF00268(Ribonuc_red_sm) | 5 | GLY A 279ASP A 73VAL A 202ARG A 278ILE A 269 | None | 0.90A | 4q5mA-2aniA:undetectable | 4q5mA-2aniA:22.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ani | RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASEBETA SUBUNIT (Chlamydiatrachomatis) |
PF00268(Ribonuc_red_sm) | 5 | GLY A 279ASP A 73VAL A 202ARG A 278ILE A 289 | None | 0.92A | 4q5mA-2aniA:undetectable | 4q5mA-2aniA:22.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2b24 | NAPHTHALENEDIOXYGENASE LARGESUBUNITNAPHTHALENEDIOXYGENASE SMALLSUBUNIT (Rhodococcus sp.NCIMB 12038) |
PF00355(Rieske)PF00848(Ring_hydroxyl_A)PF00866(Ring_hydroxyl_B) | 5 | GLY B 643ILE B 670VAL B 567ILE A 364THR B 672 | None | 1.00A | 4q5mA-2b24B:undetectable | 4q5mA-2b24B:20.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2b6n | PROTEINASE K (Serratia sp.GF96) |
PF00082(Peptidase_S8) | 5 | GLY A 181ILE A 13THR A 76VAL A 73THR A 249 | None | 1.00A | 4q5mA-2b6nA:undetectable | 4q5mA-2b6nA:24.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2e28 | PYRUVATE KINASE (Geobacillusstearothermophilus) |
PF00224(PK)PF00391(PEP-utilizers)PF02887(PK_C) | 5 | GLY A 536ILE A 531THR A 561VAL A 545ILE A 525 | None | 0.88A | 4q5mA-2e28A:undetectable | 4q5mA-2e28A:18.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2fmb | EQUINE INFECTIOUSANEMIA VIRUSPROTEASE (Equineinfectiousanemia virus) |
PF00077(RVP) | 5 | GLY A 27ASP A 29ILE A 53PRO A 86VAL A 87 | LP1 A 201 (-3.8A)LP1 A 201 (-3.6A)LP1 A 201 (-4.6A)LP1 A 201 (-3.9A)LP1 A 201 ( 4.9A) | 0.62A | 4q5mA-2fmbA:12.7 | 4q5mA-2fmbA:24.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2gz6 | N-ACETYL-D-GLUCOSAMINE 2-EPIMERASE (Anabaena sp.CH1) |
PF07221(GlcNAc_2-epim) | 6 | GLY A 316ILE A 270ILE A 247ARG A 322ILE A 250THR A 259 | None | 1.40A | 4q5mA-2gz6A:undetectable | 4q5mA-2gz6A:19.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2iyo | 6-PHOSPHOGLUCONATEDEHYDROGENASE,DECARBOXYLATING (Lactococcuslactis) |
PF00393(6PGD)PF03446(NAD_binding_2) | 5 | GLY A 180ASN A 102ILE A 98THR A 80ILE A 96 | None6PG A1471 (-2.9A)NoneNoneNone | 1.03A | 4q5mA-2iyoA:undetectable | 4q5mA-2iyoA:19.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2k3y | CHROMATINMODIFICATION-RELATEDPROTEIN EAF3 (Saccharomycescerevisiae) |
PF11717(Tudor-knot) | 5 | GLY A 83ILE A 79PRO A 46VAL A 14ILE A 27 | None | 1.01A | 4q5mA-2k3yA:undetectable | 4q5mA-2k3yA:18.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qgy | ENOLASE FROM THEENVIRONMENTAL GENOMESHOTGUN SEQUENCINGOF THE SARGASSO SEA (-) |
PF02746(MR_MLE_N)PF13378(MR_MLE_C) | 5 | ASN A 293ILE A 262VAL A 247VAL A 315ILE A 274 | None | 1.01A | 4q5mA-2qgyA:undetectable | 4q5mA-2qgyA:19.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qgy | ENOLASE FROM THEENVIRONMENTAL GENOMESHOTGUN SEQUENCINGOF THE SARGASSO SEA (-) |
PF02746(MR_MLE_N)PF13378(MR_MLE_C) | 5 | GLY A 294ASN A 265ILE A 286VAL A 247ILE A 283 | None | 1.02A | 4q5mA-2qgyA:undetectable | 4q5mA-2qgyA:19.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r1d | NEUREXIN-1-BETA (Rattusnorvegicus) |
PF02210(Laminin_G_2) | 5 | GLY A 70ILE A 169VAL A 104VAL A 192ILE A 167 | None | 0.95A | 4q5mA-2r1dA:undetectable | 4q5mA-2r1dA:23.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2raq | CONSERVED PROTEINMTH889 (Methanothermobacterthermautotrophicus) |
PF02680(DUF211) | 5 | ASP A 59ASN A 58ILE A 7VAL A 37ILE A 76 | None | 0.99A | 4q5mA-2raqA:undetectable | 4q5mA-2raqA:18.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2rkf | PROTEASE RETROPEPSIN (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 5 | GLY A 27ASP A 29ILE A 50THR A 80PRO A 81 | AB1 A 501 (-3.9A)AB1 A 501 ( 3.3A)AB1 A 501 (-3.8A)NoneAB1 A 501 (-4.2A) | 0.40A | 4q5mA-2rkfA:18.1 | 4q5mA-2rkfA:42.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2w8z | 6-PHOSPHOGLUCONATEDEHYDROGENASE,DECARBOXYLATING (Geobacillusstearothermophilus) |
PF00393(6PGD)PF03446(NAD_binding_2) | 5 | GLY A 178ASN A 102ILE A 98THR A 80ILE A 96 | None6PG A1470 (-3.1A)NoneNoneNone | 1.01A | 4q5mA-2w8zA:undetectable | 4q5mA-2w8zA:17.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xb6 | NEUREXIN-1-BETA (Rattusnorvegicus) |
PF02210(Laminin_G_2) | 5 | GLY C 116ILE C 245VAL C 150VAL C 268ILE C 243 | EDO C1295 ( 4.6A)NoneNoneNoneNone | 1.01A | 4q5mA-2xb6C:undetectable | 4q5mA-2xb6C:24.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xdr | BETAINE ALDEHYDEDEHYDROGENASE (Pseudomonasaeruginosa) |
PF00171(Aldedh) | 5 | ASP A 399ILE A 395VAL A 420ARG A 296THR A 375 | None | 0.92A | 4q5mA-2xdrA:undetectable | 4q5mA-2xdrA:19.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xr1 | CLEAVAGE ANDPOLYADENYLATIONSPECIFICITY FACTOR100 KD SUBUNIT (Methanosarcinamazei) |
PF07521(RMMBL)PF07650(KH_2)PF10996(Beta-Casp)PF16661(Lactamase_B_6)PF17214(KH_7) | 5 | ILE A 104ILE A 148PRO A 98VAL A 274THR A 144 | None | 1.00A | 4q5mA-2xr1A:undetectable | 4q5mA-2xr1A:17.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2yfq | NAD-SPECIFICGLUTAMATEDEHYDROGENASE (Peptoniphilusasaccharolyticus) |
PF00208(ELFV_dehydrog)PF02812(ELFV_dehydrog_N) | 5 | ILE A 339PRO A 298VAL A 297VAL A 403ILE A 345 | None | 1.03A | 4q5mA-2yfqA:undetectable | 4q5mA-2yfqA:19.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zyg | 6-PHOSPHOGLUCONATEDEHYDROGENASE,DECARBOXYLATING (Klebsiellapneumoniae) |
PF00393(6PGD)PF03446(NAD_binding_2) | 5 | GLY A 179ASN A 102ILE A 98THR A 80ILE A 96 | None | 0.96A | 4q5mA-2zygA:undetectable | 4q5mA-2zygA:18.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3asi | NEUREXIN-1-ALPHA (Bos taurus) |
PF02210(Laminin_G_2) | 5 | GLY A1118ILE A1217VAL A1152VAL A1240ILE A1215 | None | 0.97A | 4q5mA-3asiA:undetectable | 4q5mA-3asiA:20.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3cgy | VIRULENCE SENSORHISTIDINE KINASEPHOQ (Salmonellaenterica) |
PF02518(HATPase_c) | 5 | GLY A 385ILE A 412VAL A 399VAL A 341ILE A 367 | None | 1.04A | 4q5mA-3cgyA:undetectable | 4q5mA-3cgyA:21.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3clq | UNCHARACTERIZEDPROTEIN (Enterococcusfaecalis) |
PF06545(DUF1116) | 5 | GLY A 317ASP A 356ILE A 440ARG A 315VAL A 161 | None | 1.00A | 4q5mA-3clqA:undetectable | 4q5mA-3clqA:21.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3fdu | PUTATIVE ENOYL-COAHYDRATASE/ISOMERASE (Acinetobacterbaumannii) |
PF00378(ECH_1) | 5 | GLY A 114ASN A 33ILE A 26VAL A 121VAL A 191 | None | 0.94A | 4q5mA-3fduA:undetectable | 4q5mA-3fduA:22.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3fs2 | 2-DEHYDRO-3-DEOXYPHOSPHOOCTONATEALDOLASE (Brucellamelitensis) |
PF00793(DAHP_synth_1) | 5 | GLY A 75ASP A 61ILE A 98PRO A 109VAL A 110 | None | 0.88A | 4q5mA-3fs2A:undetectable | 4q5mA-3fs2A:23.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3gyb | TRANSCRIPTIONALREGULATORS(LACI-FAMILYTRANSCRIPTIONALREGULATORY PROTEIN) (Corynebacteriumglutamicum) |
PF13377(Peripla_BP_3) | 5 | GLY A 144ASN A 288ILE A 82PRO A 273VAL A 68 | None | 1.01A | 4q5mA-3gybA:undetectable | 4q5mA-3gybA:21.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3iyl | VP1 (Aquareovirus C) |
PF06016(Reovirus_L2) | 5 | ILE W 842PRO W 741VAL W 740VAL W 852ILE W 846 | None | 0.87A | 4q5mA-3iylW:undetectable | 4q5mA-3iylW:10.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3khj | INOSINE-5-MONOPHOSPHATE DEHYDROGENASE (Cryptosporidiumparvum) |
PF00478(IMPDH) | 5 | GLY A 190ILE A 235VAL A 159ILE A 68THR A 36 | None | 0.97A | 4q5mA-3khjA:undetectable | 4q5mA-3khjA:20.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3mqt | MANDELATERACEMASE/MUCONATELACTONIZING PROTEIN (Shewanellapealeana) |
PF02746(MR_MLE_N)PF13378(MR_MLE_C) | 5 | GLY A 96ILE A 92ARG A 95ILE A 56THR A 89 | None | 1.04A | 4q5mA-3mqtA:undetectable | 4q5mA-3mqtA:22.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3mw2 | NEUREXIN-1-ALPHA (Mus musculus) |
PF02210(Laminin_G_2) | 5 | GLY A 116ILE A 245VAL A 150VAL A 268ILE A 243 | None | 0.88A | 4q5mA-3mw2A:undetectable | 4q5mA-3mw2A:22.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3mw3 | NEUREXIN-2-BETA (Rattusnorvegicus) |
PF02210(Laminin_G_2) | 5 | GLY A 118ILE A 247VAL A 152VAL A 270ILE A 245 | None | 1.00A | 4q5mA-3mw3A:undetectable | 4q5mA-3mw3A:20.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3mw4 | NEUREXIN-2-BETA (Mus musculus) |
PF02210(Laminin_G_2) | 5 | GLY A 114ILE A 213VAL A 148VAL A 236ILE A 211 | None | 1.00A | 4q5mA-3mw4A:undetectable | 4q5mA-3mw4A:23.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3mws | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 7 | GLY A 27ASP A 29ILE A 47ILE A 50THR A 80PRO A 81VAL A 82 | None | 0.51A | 4q5mA-3mwsA:16.8 | 4q5mA-3mwsA:39.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3nfb | BETA-PEPTIDYLAMINOPEPTIDASE (Sphingosinicellaxenopeptidilytica) |
PF03576(Peptidase_S58) | 5 | GLY A 158ILE A 55VAL A 169VAL A 27ILE A 21 | None | 0.84A | 4q5mA-3nfbA:undetectable | 4q5mA-3nfbA:19.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3noy | 4-HYDROXY-3-METHYLBUT-2-EN-1-YLDIPHOSPHATE SYNTHASE (Aquifexaeolicus) |
PF04551(GcpE) | 5 | GLY A 96ILE A 79THR A 33VAL A 12ILE A 53 | None | 0.94A | 4q5mA-3noyA:undetectable | 4q5mA-3noyA:20.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3nvn | PLEXIN-C1 (Homo sapiens) |
PF01437(PSI) | 5 | GLY B 56ILE B 49THR B 125VAL B 447ILE B 46 | None | 0.84A | 4q5mA-3nvnB:undetectable | 4q5mA-3nvnB:18.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ohn | OUTER MEMBRANE USHERPROTEIN FIMD (Escherichiacoli) |
PF00577(Usher) | 5 | ASP A 274ILE A 303THR A 314VAL A 315VAL A 280 | None | 1.00A | 4q5mA-3ohnA:undetectable | 4q5mA-3ohnA:18.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ox4 | ALCOHOLDEHYDROGENASE 2 (Zymomonasmobilis) |
PF00465(Fe-ADH) | 5 | GLY A 17ILE A 136VAL A 11VAL A 51ILE A 93 | None | 0.81A | 4q5mA-3ox4A:undetectable | 4q5mA-3ox4A:20.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3poy | NEUREXIN-1-ALPHA (Bos taurus) |
PF00008(EGF)PF02210(Laminin_G_2) | 5 | GLY A1178ILE A1307VAL A1212VAL A1330ILE A1305 | None | 0.86A | 4q5mA-3poyA:undetectable | 4q5mA-3poyA:11.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qcw | NEUREXIN-1-ALPHA (Bos taurus) |
PF00008(EGF)PF02210(Laminin_G_2) | 5 | GLY A1162ILE A1291VAL A1196VAL A1314ILE A1289 | None | 0.97A | 4q5mA-3qcwA:undetectable | 4q5mA-3qcwA:11.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qo6 | PROTEASE DO-LIKE 1,CHLOROPLASTIC (Arabidopsisthaliana) |
PF13180(PDZ_2)PF13365(Trypsin_2) | 5 | GLY A 237ILE A 300ILE A 296THR A 273VAL A 169 | None | 1.04A | 4q5mA-3qo6A:undetectable | 4q5mA-3qo6A:22.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3t3c | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 5 | GLY A 27ASP A 29ILE A 47ILE A 50THR A 80 | 017 A 201 (-3.4A)017 A 201 (-3.5A)None017 A 201 (-3.3A)None | 0.64A | 4q5mA-3t3cA:15.9 | 4q5mA-3t3cA:37.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ttp | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 5 | GLY A 27ASP A 29ILE A 50THR A 80PRO A 81 | 017 A 201 (-3.6A)017 A 201 (-3.3A)017 A 201 (-3.3A)None017 A 201 (-4.1A) | 0.53A | 4q5mA-3ttpA:16.7 | 4q5mA-3ttpA:39.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3u7s | POL POLYPROTEIN (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 5 | GLY A 27ASP A 29ILE A 50THR A 80PRO A 81 | 017 A 201 ( 3.5A)017 A 201 (-3.2A)017 A 201 ( 3.5A)None017 A 202 (-4.0A) | 0.55A | 4q5mA-3u7sA:17.0 | 4q5mA-3u7sA:38.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3uhl | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | GLY A 27ASP A 29ASN A 30THR A 80PRO A 81VAL A 82 | None | 0.58A | 4q5mA-3uhlA:13.8 | 4q5mA-3uhlA:39.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3uve | CARVEOLDEHYDROGENASE((+)-TRANS-CARVEOLDEHYDROGENASE) (Mycobacteriumavium) |
PF13561(adh_short_C2) | 6 | GLY A 111ILE A 39VAL A 136VAL A 207ILE A 253THR A 209 | NoneNAD A 300 (-3.8A)NoneNAD A 300 (-4.1A)NoneNAD A 300 (-2.7A) | 1.10A | 4q5mA-3uveA:undetectable | 4q5mA-3uveA:21.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4atf | BETA-AGARASE B (Zobelliagalactanivorans) |
PF00722(Glyco_hydro_16) | 6 | GLY A 248ILE A 63ILE A 347VAL A 342VAL A 153ILE A 80 | None | 1.50A | 4q5mA-4atfA:undetectable | 4q5mA-4atfA:20.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4e09 | PLASMID PARTITIONINGPROTEIN PARF (Escherichiacoli) |
PF01656(CbiA) | 5 | GLY A 14ASN A 21ILE A 194ILE A 137ILE A 154 | ACP A 301 (-3.2A)NoneNoneNoneNone | 0.92A | 4q5mA-4e09A:undetectable | 4q5mA-4e09A:22.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ehc | PE-PGRS FAMILYPROTEIN (Mycobacteriumtuberculosis) |
no annotation | 6 | GLY A 249ILE A 216VAL A 172VAL A 210ILE A 176THR A 232 | NoneNoneNoneEDO A 326 (-4.9A)NoneNone | 1.37A | 4q5mA-4ehcA:11.2 | 4q5mA-4ehcA:22.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4gz8 | SEMAPHORIN-3A (Mus musculus) |
PF01403(Sema) | 6 | GLY A 337ASN A 428ILE A 451THR A 488VAL A 340ILE A 434 | None | 1.32A | 4q5mA-4gz8A:undetectable | 4q5mA-4gz8A:18.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4h7n | ALDEHYDEDEHYDROGENASE (Trichormusvariabilis) |
PF00171(Aldedh) | 5 | GLY A 190ASN A 195ILE A 19VAL A 156VAL A 7 | None | 1.03A | 4q5mA-4h7nA:undetectable | 4q5mA-4h7nA:19.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hvl | MEMBRANE-ANCHOREDMYCOSIN MYCP1 (Mycolicibacteriumthermoresistibile) |
PF00082(Peptidase_S8) | 5 | GLY A 195ILE A 188THR A 39VAL A 233ILE A 201 | NoneNoneIMD A 509 ( 3.8A)NoneNone | 0.96A | 4q5mA-4hvlA:undetectable | 4q5mA-4hvlA:20.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hw6 | HYPOTHETICALPROTEIN, IPT/TIGDOMAIN PROTEIN (Bacteroidesovatus) |
PF01833(TIG) | 5 | GLY A 62ILE A 104VAL A 114ARG A 63ILE A 94 | None | 1.04A | 4q5mA-4hw6A:undetectable | 4q5mA-4hw6A:18.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4i6m | ACTIN-LIKE PROTEINARP9 (Saccharomycescerevisiae) |
PF00022(Actin) | 5 | ILE B 335VAL B 329VAL B 164ILE B 309THR B 340 | None | 0.90A | 4q5mA-4i6mB:undetectable | 4q5mA-4i6mB:17.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4if2 | PHOSPHOTRIESTERASEHOMOLOGY PROTEIN (Mycobacteriumtuberculosis) |
PF02126(PTE) | 5 | GLY A 96ILE A 27VAL A 66ILE A 205THR A 148 | KCX A 145 ( 3.4A)NoneNoneNoneNone | 1.03A | 4q5mA-4if2A:undetectable | 4q5mA-4if2A:20.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4iug | BETA-GALACTOSIDASE A (Aspergillusoryzae) |
PF01301(Glyco_hydro_35)PF10435(BetaGal_dom2)PF13363(BetaGal_dom3)PF13364(BetaGal_dom4_5) | 5 | GLY A 857ASN A 352ILE A 797VAL A 795ILE A 819 | None | 1.03A | 4q5mA-4iugA:undetectable | 4q5mA-4iugA:13.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ix2 | INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE (Vibrio cholerae) |
PF00478(IMPDH) | 5 | GLY A 278ILE A 323VAL A 246ILE A 69THR A 37 | None | 1.02A | 4q5mA-4ix2A:undetectable | 4q5mA-4ix2A:19.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4jen | CMP N-GLYCOSIDASE (Clostridiumbotulinum) |
no annotation | 5 | ASP A 45ILE A 71ILE A 104THR A 89ILE A 130 | None | 0.96A | 4q5mA-4jenA:undetectable | 4q5mA-4jenA:21.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4k8l | PROLINE RACEMASE (Ochrobactrumanthropi) |
PF05544(Pro_racemase) | 5 | ILE A 245ILE A 201THR A 242VAL A 157ILE A 163 | None | 0.94A | 4q5mA-4k8lA:undetectable | 4q5mA-4k8lA:20.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ld6 | PWWPDOMAIN-CONTAININGPROTEIN 2B (Homo sapiens) |
PF00855(PWWP) | 6 | GLY A 496ILE A 541ARG A 554VAL A 488ILE A 511THR A 482 | None | 1.01A | 4q5mA-4ld6A:undetectable | 4q5mA-4ld6A:19.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mwa | 4-HYDROXY-3-METHYLBUT-2-EN-1-YLDIPHOSPHATE SYNTHASE (Bacillusanthracis) |
PF04551(GcpE) | 5 | GLY D 98ILE D 73VAL D 59ILE D 46THR D 36 | None | 1.01A | 4q5mA-4mwaD:undetectable | 4q5mA-4mwaD:23.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4n6e | THIS/MOAD FAMILYPROTEIN (Amycolatopsisorientalis) |
PF02597(ThiS) | 6 | ASP B 64ILE B 83THR B 80VAL B 3ARG B 66ILE B 42 | None | 1.46A | 4q5mA-4n6eB:undetectable | 4q5mA-4n6eB:18.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4njv | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | GLY A 27ASP A 29ILE A 47ILE A 50THR A 80PRO A 81 | RIT A 500 (-3.9A)RIT A 500 (-3.2A)RIT A 500 ( 4.5A)RIT A 500 (-4.3A)NoneRIT A 500 (-3.9A) | 0.48A | 4q5mA-4njvA:17.6 | 4q5mA-4njvA:43.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4o1e | DIHYDROPTEROATESYNTHASE DHPS (Desulfitobacteriumhafniense) |
PF00809(Pterin_bind) | 5 | GLY A 94ILE A 3ILE A 43VAL A 65ILE A 9 | None | 0.98A | 4q5mA-4o1eA:undetectable | 4q5mA-4o1eA:24.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4o6v | OXIDOREDUCTASE,SHORT-CHAINDEHYDROGENASE/REDUCTASE FAMILY (Brucella suis) |
PF13561(adh_short_C2) | 5 | GLY A 228ILE A 204VAL A 175ILE A 132THR A 207 | None | 0.97A | 4q5mA-4o6vA:undetectable | 4q5mA-4o6vA:22.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4oj5 | TAILSPIKE PROTEIN (Escherichiavirus CBA120) |
no annotation | 6 | GLY A 647ILE A 675ILE A 589PRO A 641VAL A 643ILE A 607 | None | 1.29A | 4q5mA-4oj5A:undetectable | 4q5mA-4oj5A:14.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4p22 | UBIQUITIN-LIKEMODIFIER-ACTIVATINGENZYME 1 (Homo sapiens) |
PF00899(ThiF)PF16190(E1_FCCH)PF16191(E1_4HB) | 6 | ASP A 393ILE A 397ILE A 87ARG A 81VAL A 77ILE A 91 | None | 1.29A | 4q5mA-4p22A:undetectable | 4q5mA-4p22A:17.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4q3m | MGS-M4 (unidentified) |
PF00248(Aldo_ket_red) | 5 | GLY A 37ILE A 68ILE A 15VAL A 243ILE A 217 | None | 0.97A | 4q5mA-4q3mA:undetectable | 4q5mA-4q3mA:22.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qc8 | VP2 (Ungulatebocaparvovirus1) |
PF00740(Parvo_coat) | 5 | GLY A 158ILE A 70ILE A 453VAL A 133ILE A 451 | None | 1.00A | 4q5mA-4qc8A:undetectable | 4q5mA-4qc8A:16.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4yhg | GH5 (Bacteroidetesbacterium AC2a) |
PF00150(Cellulase) | 5 | ASP A 227ASN A 225ILE A 334VAL A 219ARG A 287 | None | 1.04A | 4q5mA-4yhgA:undetectable | 4q5mA-4yhgA:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5cju | ISOBUTYRYL-COAMUTASE FUSED (Cupriavidusmetallidurans) |
PF01642(MM_CoA_mutase)PF02310(B12-binding)PF03308(ArgK) | 5 | GLY A 106ILE A 159ILE A 81VAL A 69ILE A 83 | None | 1.00A | 4q5mA-5cjuA:undetectable | 4q5mA-5cjuA:10.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5eb5 | HNL ISOENZYME 5 (Prunus dulcis) |
PF00732(GMC_oxred_N)PF05199(GMC_oxred_C) | 5 | GLY A 252VAL A 510ARG A 249VAL A 234ILE A 32 | None | 1.01A | 4q5mA-5eb5A:undetectable | 4q5mA-5eb5A:16.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5eft | P9-1 (Southern riceblack-streakeddwarf virus) |
PF06043(Reo_P9) | 5 | GLY B 208ASN B 212ILE B 14VAL B 220THR B 8 | None | 0.94A | 4q5mA-5eftB:undetectable | 4q5mA-5eftB:19.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ej2 | CARVEOLDEHYDROGENASE (Mycobacteriumavium) |
PF13561(adh_short_C2) | 6 | GLY A 115ILE A 47VAL A 140VAL A 211ILE A 257THR A 213 | NoneNAD A 300 (-3.8A)NoneNAD A 300 (-4.2A)NoneNAD A 300 (-2.6A) | 1.10A | 4q5mA-5ej2A:undetectable | 4q5mA-5ej2A:20.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5fwm | HEAT SHOCK PROTEINHSP 90 BETA (Homo sapiens) |
PF00183(HSP90)PF02518(HATPase_c) | 5 | ILE A 182ILE A 75THR A 179VAL A 202ILE A 213 | NoneNoneATP A1691 (-4.4A)NoneNone | 0.99A | 4q5mA-5fwmA:undetectable | 4q5mA-5fwmA:14.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5n1q | METHYL-COENZYME MREDUCTASE III FROMMETHANOTHERMOCOCCUSTHERMOLITHOTROPHICUSSUBUNIT BETAMETHYL-COENZYME MREDUCTASE III FROMMETHANOTHERMOCOCCUSTHERMOLITHOTROPHICUSSUBUNIT GAMMA (Methanothermococcusthermolithotrophicus) |
PF02240(MCR_gamma)PF02241(MCR_beta)PF02783(MCR_beta_N) | 5 | GLY B 346ILE B 331VAL B 267ARG C 245THR B 355 | None | 1.04A | 4q5mA-5n1qB:undetectable | 4q5mA-5n1qB:19.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5n6y | NITROGENASEVANADIUM-IRONPROTEIN BETA CHAIN (Azotobactervinelandii) |
no annotation | 6 | ASN E 260ILE E 293THR E 279PRO E 280VAL E 210THR E 297 | None | 1.20A | 4q5mA-5n6yE:undetectable | 4q5mA-5n6yE:19.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ngy | DSR-M GLUCANSUCRASEINACTIVE MUTANTE715Q (Leuconostoccitreum) |
no annotation | 6 | GLY A 631ASP A 633ASN A1274ILE A 581ILE A1278ILE A 565 | None CA A1501 (-2.3A)NoneNoneNoneNone | 1.46A | 4q5mA-5ngyA:undetectable | 4q5mA-5ngyA:9.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5osn | CAPSID PROTEIN (Enterovirus E) |
PF00073(Rhv) | 5 | GLY A 84ASP A 220VAL A 121VAL A 136ILE A 116 | None | 0.98A | 4q5mA-5osnA:undetectable | 4q5mA-5osnA:20.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5t2z | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | GLY A 27ASP A 29ILE A 47ILE A 50THR A 80PRO A 81 | None | 0.53A | 4q5mA-5t2zA:17.5 | 4q5mA-5t2zA:40.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1b0k | PROTEIN (ACONITASE) (Sus scrofa) |
PF00330(Aconitase)PF00694(Aconitase_C) | 5 | GLY A 176ILE A 179GLY A 163ILE A 177ILE A 150 | None | 1.01A | 4q5mA-1b0kA:undetectable | 4q5mA-1b0kA:15.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1bs0 | PROTEIN(8-AMINO-7-OXONANOATE SYNTHASE) (Escherichiacoli) |
PF00155(Aminotran_1_2) | 5 | VAL A 177GLY A 213GLY A 237ILE A 212ILE A 283 | None | 0.99A | 4q5mA-1bs0A:undetectable | 4q5mA-1bs0A:21.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1dle | COMPLEMENT FACTOR B (Homo sapiens) |
PF00089(Trypsin) | 5 | VAL A 66ILE A 33GLY A 196ASP A 102ILE A 106 | None | 0.85A | 4q5mA-1dleA:undetectable | 4q5mA-1dleA:19.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1gaj | HIGH-AFFINITYBRANCHED CHAIN AMINOACID TRANSPORTATP-BINDING PROTEIN (Methanocaldococcusjannaschii) |
PF00005(ABC_tran) | 5 | GLY A 165ILE A 192GLY A 157ILE A 164VAL A 99 | None | 0.92A | 4q5mA-1gajA:undetectable | 4q5mA-1gajA:25.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1h4p | GLUCAN1,3-BETA-GLUCOSIDASEI/II (Saccharomycescerevisiae) |
PF00150(Cellulase) | 5 | ARG A 403GLY A 226GLY A 404ASP A 45ILE A 266 | GOL A1451 (-4.1A)NoneNoneGOL A1451 (-3.9A)None | 0.83A | 4q5mA-1h4pA:undetectable | 4q5mA-1h4pA:17.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 5 | ALA A 28VAL A 32GLY A 48ILE A 84ILE A 50 | A79 A 800 (-3.1A)A79 A 800 ( 4.4A)A79 A 800 (-3.6A)A79 A 800 (-3.6A)A79 A 800 ( 4.0A) | 1.01A | 4q5mA-1hvcA:33.5 | 4q5mA-1hvcA:95.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 11 | ALA A 28VAL A 32GLY A 49ILE A 84GLY A 27ASP A 29GLY A 49ILE A 50PRO A 81VAL A 82ILE A 84 | A79 A 800 (-3.1A)A79 A 800 ( 4.4A)A79 A 800 ( 3.7A)A79 A 800 (-3.6A)A79 A 800 (-3.0A)A79 A 800 (-2.7A)A79 A 800 (-3.4A)A79 A 800 ( 4.0A)A79 A 800 ( 3.4A)A79 A 800 (-4.5A)A79 A 800 (-3.8A) | 0.53A | 4q5mA-1hvcA:33.5 | 4q5mA-1hvcA:95.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 11 | ALA A 28VAL A 32GLY A 49ILE A 84GLY A 27ASP A 29GLY A 49ILE A 50PRO A 81VAL A 82ILE A 84 | A79 A 800 (-3.2A)A79 A 800 ( 4.3A)A79 A 800 (-3.4A)A79 A 800 (-3.8A)A79 A 800 (-3.0A)A79 A 800 (-2.8A)A79 A 800 ( 3.7A)A79 A 800 (-3.8A)A79 A 800 ( 3.9A)A79 A 800 (-4.5A)A79 A 800 (-3.6A) | 0.55A | 4q5mA-1hvcA:33.5 | 4q5mA-1hvcA:95.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 11 | ARG A 8ALA A 28VAL A 32GLY A 49GLY A 27ASP A 29GLY A 49ILE A 50PRO A 81VAL A 82ILE A 84 | A79 A 800 (-3.4A)A79 A 800 (-3.1A)A79 A 800 ( 4.4A)A79 A 800 ( 3.7A)A79 A 800 (-3.0A)A79 A 800 (-2.7A)A79 A 800 (-3.4A)A79 A 800 ( 4.0A)A79 A 800 ( 3.4A)A79 A 800 (-4.5A)A79 A 800 (-3.8A) | 0.58A | 4q5mA-1hvcA:33.5 | 4q5mA-1hvcA:95.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 11 | ARG A 8ALA A 28VAL A 32GLY A 49GLY A 27ASP A 29GLY A 49ILE A 50PRO A 81VAL A 82ILE A 84 | A79 A 800 (-3.6A)A79 A 800 (-3.2A)A79 A 800 ( 4.3A)A79 A 800 (-3.4A)A79 A 800 (-3.0A)A79 A 800 (-2.8A)A79 A 800 ( 3.7A)A79 A 800 (-3.8A)A79 A 800 ( 3.9A)A79 A 800 (-4.5A)A79 A 800 (-3.6A) | 0.61A | 4q5mA-1hvcA:33.5 | 4q5mA-1hvcA:95.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | ARG A 8ASP A 29GLY A 48PRO A 81VAL A 82ILE A 84 | A79 A 800 (-3.4A)A79 A 800 (-2.7A)A79 A 800 (-4.1A)A79 A 800 ( 3.4A)A79 A 800 (-4.5A)A79 A 800 (-3.8A) | 0.91A | 4q5mA-1hvcA:33.5 | 4q5mA-1hvcA:95.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1i2d | ATP SULFURYLASE (Penicilliumchrysogenum) |
PF01583(APS_kinase)PF01747(ATP-sulfurylase)PF14306(PUA_2) | 5 | ARG A 437ALA A 474ILE A 458GLY A 433VAL A 502 | ADX A 575 (-3.7A)NoneNoneADX A 575 ( 4.3A)None | 0.97A | 4q5mA-1i2dA:undetectable | 4q5mA-1i2dA:16.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1jg3 | PROTEIN-L-ISOASPARTATEO-METHYLTRANSFERASE (Pyrococcusfuriosus) |
PF01135(PCMT) | 5 | ILE A 162GLY A 152ASP A 148GLY A 99ILE A 145 | NoneNoneADN A 500 (-3.7A)ADN A 500 (-3.2A) CL A 300 ( 4.7A) | 0.91A | 4q5mA-1jg3A:undetectable | 4q5mA-1jg3A:22.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1jny | ELONGATION FACTOR1-ALPHA (Sulfolobussolfataricus) |
PF00009(GTP_EFTU)PF03143(GTP_EFTU_D3)PF03144(GTP_EFTU_D2) | 5 | GLY A 422ASP A 414GLY A 420ILE A 330VAL A 349 | None | 0.90A | 4q5mA-1jnyA:undetectable | 4q5mA-1jnyA:19.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1kve | SMK TOXIN (Millerozymafarinosa) |
no annotation | 5 | ALA B 189GLY B 153GLY B 155ILE B 203PRO B 214 | None | 1.01A | 4q5mA-1kveB:undetectable | 4q5mA-1kveB:18.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ou0 | PRECORRIN-8XMETHYLMUTASE RELATEDPROTEIN (Thermoplasmaacidophilum) |
PF02570(CbiC) | 5 | ALA A 40GLY A 190ILE A 198GLY A 135ILE A 161 | None | 0.78A | 4q5mA-1ou0A:undetectable | 4q5mA-1ou0A:23.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1poi | GLUTACONATE COENZYMEA-TRANSFERASE (Acidaminococcusfermentans) |
PF01144(CoA_trans) | 5 | VAL A 189GLY A 194ASP A 29GLY A 24ILE A 178 | None | 1.03A | 4q5mA-1poiA:undetectable | 4q5mA-1poiA:21.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1rtk | COMPLEMENT FACTOR B (Homo sapiens) |
PF00089(Trypsin)PF00092(VWA) | 5 | VAL A 514ILE A 474GLY A 675ASP A 551ILE A 555 | None | 0.99A | 4q5mA-1rtkA:undetectable | 4q5mA-1rtkA:15.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1si1 | IRON BINDING PROTEINFBPA (Mannheimiahaemolytica) |
PF13343(SBP_bac_6) | 5 | VAL A 271GLY A 233ASP A 93VAL A 54ILE A 236 | None | 1.03A | 4q5mA-1si1A:undetectable | 4q5mA-1si1A:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1si1 | IRON BINDING PROTEINFBPA (Mannheimiahaemolytica) |
PF13343(SBP_bac_6) | 5 | VAL A 271GLY A 233ILE A 84VAL A 54ILE A 236 | None | 0.99A | 4q5mA-1si1A:undetectable | 4q5mA-1si1A:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1siv | SIV PROTEASE (Simianimmunodeficiencyvirus) |
PF00077(RVP) | 6 | GLY A 27ASP A 29GLY A 49ILE A 50PRO A 81ILE A 84 | None | 0.60A | 4q5mA-1sivA:15.6 | 4q5mA-1sivA:28.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1uli | BIPHENYL DIOXYGENASELARGE SUBUNIT (Rhodococcusjostii) |
PF00355(Rieske)PF00848(Ring_hydroxyl_A) | 5 | ALA A 214VAL A 342GLY A 379ILE A 340ILE A 385 | None | 0.87A | 4q5mA-1uliA:undetectable | 4q5mA-1uliA:18.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1vyh | PLATELET-ACTIVATINGFACTORACETYLHYDROLASE IBALPHA SUBUNIT (Mus musculus) |
PF00400(WD40) | 5 | ALA C 166VAL C 221ILE C 207PRO C 118ILE C 115 | None | 1.03A | 4q5mA-1vyhC:undetectable | 4q5mA-1vyhC:17.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1w3f | HEMOLYTIC LECTINFROM LAETIPORUSSULPHUREUS (Laetiporussulphureus) |
PF03318(ETX_MTX2) | 5 | GLY A 241GLY A 296ILE A 297PRO A 221VAL A 220 | None | 0.96A | 4q5mA-1w3fA:undetectable | 4q5mA-1w3fA:20.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ydw | AX110P-LIKE PROTEIN (Arabidopsisthaliana) |
PF01408(GFO_IDH_MocA) | 5 | GLY A 10GLY A 95ILE A 72VAL A 77ILE A 98 | None | 1.01A | 4q5mA-1ydwA:undetectable | 4q5mA-1ydwA:19.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1zjk | MANNAN-BINDINGLECTIN SERINEPROTEASE 2 (Homo sapiens) |
PF00084(Sushi)PF00089(Trypsin) | 5 | ALA A 481ILE A 652GLY A 470VAL A 517ILE A 536 | None | 0.92A | 4q5mA-1zjkA:undetectable | 4q5mA-1zjkA:17.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2csu | 457AA LONGHYPOTHETICAL PROTEIN (Pyrococcushorikoshii) |
PF13380(CoA_binding_2)PF13607(Succ_CoA_lig) | 5 | ARG A 123GLY A 131ASP A 187ILE A 132ILE A 94 | None | 1.01A | 4q5mA-2csuA:undetectable | 4q5mA-2csuA:20.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2dup | VESICULARINTEGRAL-MEMBRANEPROTEIN VIP36 (Canis lupus) |
PF03388(Lectin_leg-like) | 5 | ARG A 172ILE A 177GLY A 201ILE A 159ILE A 242 | None | 1.03A | 4q5mA-2dupA:undetectable | 4q5mA-2dupA:21.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2fmb | EQUINE INFECTIOUSANEMIA VIRUSPROTEASE (Equineinfectiousanemia virus) |
PF00077(RVP) | 5 | ARG A 8ALA A 28VAL A 32GLY A 55ILE A 89 | LP1 A 201 (-3.5A)LP1 A 201 (-3.5A)NoneLP1 A 201 (-3.4A)LP1 A 201 (-4.2A) | 0.51A | 4q5mA-2fmbA:12.7 | 4q5mA-2fmbA:24.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2fmb | EQUINE INFECTIOUSANEMIA VIRUSPROTEASE (Equineinfectiousanemia virus) |
PF00077(RVP) | 6 | GLY A 27ASP A 29GLY A 55PRO A 86VAL A 87ILE A 89 | LP1 A 201 (-3.8A)LP1 A 201 (-3.6A)LP1 A 201 (-3.4A)LP1 A 201 (-3.9A)LP1 A 201 ( 4.9A)LP1 A 201 (-4.2A) | 0.47A | 4q5mA-2fmbA:12.7 | 4q5mA-2fmbA:24.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2i6u | ORNITHINECARBAMOYLTRANSFERASE (Mycobacteriumtuberculosis) |
PF00185(OTCace)PF02729(OTCace_N) | 5 | GLY A 173ILE A 139GLY A 144GLY A 148ILE A 174 | None | 0.96A | 4q5mA-2i6uA:undetectable | 4q5mA-2i6uA:22.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2oip | CHAIN A, CRYSTALSTRUCTURE OF DHFR (Cryptosporidiumhominis) |
PF00186(DHFR_1)PF00303(Thymidylat_synt) | 5 | GLY A 305ILE A 341GLY A 320VAL A 313ILE A 315 | NoneNoneNoneNoneCB3 A 604 ( 3.7A) | 0.84A | 4q5mA-2oipA:undetectable | 4q5mA-2oipA:17.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2rhk | NON-STRUCTURALPROTEIN 1 (Influenza Avirus) |
PF00600(Flu_NS1) | 5 | VAL A 194GLY A 179GLY A 158GLY A 183ILE A 182 | NoneNoneNoneNoneNO3 A 3 ( 4.4A) | 0.94A | 4q5mA-2rhkA:undetectable | 4q5mA-2rhkA:22.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2rkf | PROTEASE RETROPEPSIN (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | GLY A 27ASP A 29GLY A 49ILE A 50PRO A 81ILE A 84 | AB1 A 501 (-3.9A)AB1 A 501 ( 3.3A)AB1 A 501 (-3.5A)AB1 A 501 (-3.8A)AB1 A 501 (-4.2A)AB1 A 501 ( 4.2A) | 0.50A | 4q5mA-2rkfA:18.1 | 4q5mA-2rkfA:42.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2v6g | PROGESTERONE5-BETA-REDUCTASE (Digitalislanata) |
PF01370(Epimerase) | 5 | VAL A 58GLY A 39ILE A 75GLY A 33ILE A 31 | NoneNoneNoneNAP A1390 (-3.1A)None | 1.01A | 4q5mA-2v6gA:undetectable | 4q5mA-2v6gA:21.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vhl | N-ACETYLGLUCOSAMINE-6-PHOSPHATEDEACETYLASE (Bacillussubtilis) |
PF01979(Amidohydro_1) | 5 | ALA A 347GLY A 352ILE A 60ILE A 353ILE A 197 | None | 0.99A | 4q5mA-2vhlA:undetectable | 4q5mA-2vhlA:20.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vvq | RIBOSE-5-PHOSPHATEISOMERASE B (Mycobacteriumtuberculosis) |
PF02502(LacAB_rpiB) | 5 | ALA A 96VAL A 124GLY A 109GLY A 111ILE A 110 | None | 1.03A | 4q5mA-2vvqA:undetectable | 4q5mA-2vvqA:20.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2w8q | SUCCINATE-SEMIALDEHYDE DEHYDROGENASE,MITOCHONDRIAL (Homo sapiens) |
PF00171(Aldedh) | 5 | ALA A 270GLY A 94ASP A 92VAL A 226ILE A 257 | None | 0.93A | 4q5mA-2w8qA:undetectable | 4q5mA-2w8qA:16.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xwb | COMPLEMENT FACTOR B (Homo sapiens) |
PF00084(Sushi)PF00089(Trypsin)PF00092(VWA) | 5 | VAL F 514ILE F 474GLY F 675ASP F 551ILE F 555 | None | 0.98A | 4q5mA-2xwbF:undetectable | 4q5mA-2xwbF:13.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zp2 | KINASE A INHIBITOR (Bacillussubtilis) |
PF02682(CT_C_D) | 5 | VAL A 130GLY A 199GLY A 178ILE A 198ILE A 104 | None | 1.03A | 4q5mA-2zp2A:undetectable | 4q5mA-2zp2A:21.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zzg | ALANYL-TRNASYNTHETASE (Pyrococcushorikoshii) |
PF01411(tRNA-synt_2c)PF07973(tRNA_SAD) | 5 | ALA A 665ILE A 731GLY A 615GLY A 726ILE A 709 | None | 0.95A | 4q5mA-2zzgA:undetectable | 4q5mA-2zzgA:13.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3agf | GLUTAMINASE 1 (Bacillussubtilis) |
PF04960(Glutaminase) | 5 | VAL A 234ILE A 235GLY A 218ILE A 220PRO A 281 | None | 1.02A | 4q5mA-3agfA:undetectable | 4q5mA-3agfA:21.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3beu | TRYPSIN (Streptomycesgriseus) |
PF00089(Trypsin) | 5 | ALA A 55ILE A 212GLY A 44VAL A 88ILE A 106 | None | 0.93A | 4q5mA-3beuA:undetectable | 4q5mA-3beuA:21.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3esh | PROTEIN SIMILAR TOMETAL-DEPENDENTHYDROLASE (Staphylococcusaureus) |
PF00753(Lactamase_B) | 5 | ARG A 273VAL A 81GLY A 67GLY A 65ILE A 66 | None | 0.79A | 4q5mA-3eshA:undetectable | 4q5mA-3eshA:20.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hh8 | METAL ABCTRANSPORTERSUBSTRATE-BINDINGLIPOPROTEIN (Streptococcuspyogenes) |
PF01297(ZnuA) | 5 | ALA A 140VAL A 124ILE A 122PRO A 66ILE A 41 | None | 0.97A | 4q5mA-3hh8A:undetectable | 4q5mA-3hh8A:19.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3kjr | DIHYDROFOLATEREDUCTASE/THYMIDYLATE SYNTHASE (Babesia bovis) |
PF00186(DHFR_1)PF00303(Thymidylat_synt) | 5 | GLY A 296ILE A 332GLY A 311VAL A 304ILE A 306 | NoneNoneNoneNoneGOL A 516 (-3.9A) | 0.80A | 4q5mA-3kjrA:undetectable | 4q5mA-3kjrA:18.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ksg | PUTATIVEUNCHARACTERIZEDPROTEIN (Staphylococcusaureus) |
PF13185(GAF_2) | 5 | ALA A 81GLY A 122GLY A 74ILE A 120ILE A 71 | NoneNoneNoneNoneSME A6888 ( 4.2A) | 0.95A | 4q5mA-3ksgA:undetectable | 4q5mA-3ksgA:23.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3kzw | CYTOSOLAMINOPEPTIDASE (Staphylococcusaureus) |
PF00883(Peptidase_M17)PF02789(Peptidase_M17_N) | 5 | ALA A 287GLY A 258GLY A 291VAL A 240ILE A 242 | None | 0.96A | 4q5mA-3kzwA:undetectable | 4q5mA-3kzwA:17.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3m5r | NONSTRUCTURALPROTEIN 1 (Influenza Avirus) |
PF00600(Flu_NS1) | 5 | VAL A 194GLY A 179GLY A 158GLY A 183ILE A 182 | None | 0.90A | 4q5mA-3m5rA:undetectable | 4q5mA-3m5rA:26.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3mws | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 7 | GLY A 27ASP A 29GLY A 49ILE A 50PRO A 81VAL A 82ILE A 84 | None | 0.60A | 4q5mA-3mwsA:16.8 | 4q5mA-3mwsA:39.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3my9 | MUCONATECYCLOISOMERASE (Azorhizobiumcaulinodans) |
PF02746(MR_MLE_N)PF13378(MR_MLE_C) | 5 | ILE A 272GLY A 297PRO A 352VAL A 351ILE A 135 | None | 0.98A | 4q5mA-3my9A:undetectable | 4q5mA-3my9A:19.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3p39 | NONSTRUCTURALPROTEIN 1 (Influenza Avirus) |
PF00600(Flu_NS1) | 5 | VAL A 189GLY A 174GLY A 153GLY A 178ILE A 177 | None | 0.88A | 4q5mA-3p39A:undetectable | 4q5mA-3p39A:24.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3q58 | N-ACETYLMANNOSAMINE-6-PHOSPHATE2-EPIMERASE (Salmonellaenterica) |
PF04131(NanE) | 5 | ALA A 103GLY A 151ILE A 70ILE A 182ILE A 147 | None | 1.03A | 4q5mA-3q58A:undetectable | 4q5mA-3q58A:21.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3r0z | D-SERINE DEHYDRATASE (Salmonellaenterica) |
PF00291(PALP) | 5 | ALA A 286VAL A 272GLY A 250GLY A 281VAL A 47 | NoneNoneNoneSO4 A 449 (-3.3A)None | 0.87A | 4q5mA-3r0zA:undetectable | 4q5mA-3r0zA:18.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3rvx | PEPTIDASE 1 (Dermatophagoidespteronyssinus) |
PF00112(Peptidase_C1) | 5 | GLY A 39ILE A 113GLY A 87GLY A 79ILE A 80 | None | 0.93A | 4q5mA-3rvxA:undetectable | 4q5mA-3rvxA:20.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3sfz | APOPTOTIC PEPTIDASEACTIVATING FACTOR 1 (Mus musculus) |
PF00400(WD40)PF00931(NB-ARC)PF12894(ANAPC4_WD40) | 5 | ALA A 919ILE A 956GLY A 951VAL A1236ILE A 926 | None | 0.94A | 4q5mA-3sfzA:undetectable | 4q5mA-3sfzA:9.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3tsd | INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE (Bacillusanthracis) |
PF00478(IMPDH)PF00571(CBS) | 5 | ALA A 247GLY A 70ILE A 277GLY A 50VAL A 85 | None | 1.02A | 4q5mA-3tsdA:undetectable | 4q5mA-3tsdA:17.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ttp | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | GLY A 27ASP A 29GLY A 49ILE A 50PRO A 81ILE A 84 | 017 A 201 (-3.6A)017 A 201 (-3.3A)017 A 201 (-3.0A)017 A 201 (-3.3A)017 A 201 (-4.1A)017 A 201 (-4.7A) | 0.58A | 4q5mA-3ttpA:16.7 | 4q5mA-3ttpA:39.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3u7s | POL POLYPROTEIN (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 5 | GLY A 27ASP A 29GLY A 49ILE A 50PRO A 81 | 017 A 201 ( 3.5A)017 A 201 (-3.2A)017 A 202 (-2.9A)017 A 201 ( 3.5A)017 A 202 (-4.0A) | 0.51A | 4q5mA-3u7sA:17.0 | 4q5mA-3u7sA:38.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3uw2 | PHOSPHOGLUCOMUTASE/PHOSPHOMANNOMUTASEFAMILY PROTEIN (Burkholderiathailandensis) |
PF00408(PGM_PMM_IV)PF02878(PGM_PMM_I)PF02879(PGM_PMM_II)PF02880(PGM_PMM_III) | 5 | VAL A 46GLY A 64ILE A 104GLY A 33ILE A 139 | None | 0.92A | 4q5mA-3uw2A:undetectable | 4q5mA-3uw2A:19.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3vis | ESTERASE (Thermobifidaalba) |
PF12740(Chlorophyllase2) | 5 | GLY A 167ILE A 113GLY A 258ILE A 95ILE A 210 | None | 0.99A | 4q5mA-3visA:undetectable | 4q5mA-3visA:21.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3w0l | GLUCOKINASEREGULATORY PROTEIN (Xenopus laevis) |
no annotation | 5 | GLY B 341ILE B 370GLY B 365GLY B 361ILE B 342 | None | 1.03A | 4q5mA-3w0lB:undetectable | 4q5mA-3w0lB:17.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wq4 | BETA-PRIMEVEROSIDASE (Camelliasinensis) |
PF00232(Glyco_hydro_1) | 5 | ILE A 149GLY A 46PRO A 494VAL A 482ILE A 481 | None | 0.91A | 4q5mA-3wq4A:undetectable | 4q5mA-3wq4A:17.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wz2 | UNCHARACTERIZEDPROTEIN (Pyrococcusfuriosus) |
PF09754(PAC2) | 5 | GLY A 131ILE A 153GLY A 129ILE A 130ILE A 111 | None | 0.89A | 4q5mA-3wz2A:undetectable | 4q5mA-3wz2A:23.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4a3s | 6-PHOSPHOFRUCTOKINASE (Bacillussubtilis) |
PF00365(PFK) | 5 | VAL A 122GLY A 15GLY A 11GLY A 138ILE A 137 | None | 0.79A | 4q5mA-4a3sA:undetectable | 4q5mA-4a3sA:20.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4cg1 | CUTINASE (Thermobifidafusca) |
PF12740(Chlorophyllase2) | 5 | GLY A 128ILE A 74GLY A 219ILE A 56ILE A 171 | None | 0.96A | 4q5mA-4cg1A:undetectable | 4q5mA-4cg1A:21.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4cxh | ELONGATION FACTOR 1A (Oryctolaguscuniculus) |
PF00009(GTP_EFTU)PF03143(GTP_EFTU_D3)PF03144(GTP_EFTU_D2) | 5 | GLY A 422ASP A 414GLY A 420ILE A 330VAL A 349 | None A Y 64 ( 3.8A)NoneNoneNone | 0.97A | 4q5mA-4cxhA:undetectable | 4q5mA-4cxhA:18.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fxg | MANNAN-BINDINGLECTIN SERINEPROTEASE 2 B CHAIN (Homo sapiens) |
PF00089(Trypsin) | 5 | ALA H 481ILE H 652GLY H 470VAL H 517ILE H 536 | None | 0.99A | 4q5mA-4fxgH:undetectable | 4q5mA-4fxgH:22.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4gnr | ABC TRANSPORTERSUBSTRATE-BINDINGPROTEIN-BRANCHEDCHAIN AMINO ACIDTRANSPORT (Streptococcuspneumoniae) |
PF13458(Peripla_BP_6) | 5 | VAL A 246ASP A 262ILE A 281VAL A 170ILE A 166 | NoneILE A 401 (-2.8A)NoneNoneNone | 0.99A | 4q5mA-4gnrA:undetectable | 4q5mA-4gnrA:20.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hpn | PUTATIVEUNCHARACTERIZEDPROTEIN (Agrobacteriumfabrum) |
PF02746(MR_MLE_N)PF13378(MR_MLE_C) | 5 | ALA A 305GLY A 46GLY A 362GLY A 44ILE A 117 | None | 1.01A | 4q5mA-4hpnA:undetectable | 4q5mA-4hpnA:20.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4k5u | VARIABLE LYMPHOCYTERECEPTOR (Petromyzonmarinus) |
no annotation | 5 | GLY B 63GLY B 18PRO B 25VAL B 24ILE B 42 | None | 0.78A | 4q5mA-4k5uB:undetectable | 4q5mA-4k5uB:22.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4kpn | NUCLEOSIDEN-RIBOHYDROLASE 1 (Physcomitrellapatens) |
PF01156(IU_nuc_hydro) | 5 | ALA A 60GLY A 27ASP A 29ILE A 51ILE A 34 | NoneNone CA A 400 ( 4.5A)NoneNone | 0.94A | 4q5mA-4kpnA:undetectable | 4q5mA-4kpnA:22.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4kpo | NUCLEOSIDEN-RIBOHYDROLASE 3 (Zea mays) |
PF01156(IU_nuc_hydro) | 5 | ALA A 43GLY A 10ASP A 12ILE A 34ILE A 17 | NoneNone CA A 401 ( 4.8A)NoneNone | 0.92A | 4q5mA-4kpoA:undetectable | 4q5mA-4kpoA:19.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4kt1 | LEUCINE-RICHREPEAT-CONTAININGG-PROTEIN COUPLEDRECEPTOR 4 (Homo sapiens) |
PF01462(LRRNT)PF13516(LRR_6)PF13855(LRR_8) | 5 | GLY A 90GLY A 45PRO A 52VAL A 51ILE A 69 | None | 0.85A | 4q5mA-4kt1A:undetectable | 4q5mA-4kt1A:17.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4l68 | LEUCINE-RICH REPEATPROTEIN KINASE-LIKEPROTEIN (Arabidopsisthaliana) |
PF07714(Pkinase_Tyr) | 5 | VAL A 434GLY A 493ILE A 435GLY A 407ILE A 430 | None | 0.90A | 4q5mA-4l68A:undetectable | 4q5mA-4l68A:19.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4m8j | L-CARNITINE/GAMMA-BUTYROBETAINEANTIPORTER (Proteusmirabilis) |
PF02028(BCCT) | 5 | VAL A 22GLY A 205GLY A 460ILE A 459ILE A 423 | None | 0.81A | 4q5mA-4m8jA:undetectable | 4q5mA-4m8jA:20.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mrq | PHOSPHOMANNOMUTASE/PHOSPHOGLUCOMUTASE (Pseudomonasaeruginosa) |
PF00408(PGM_PMM_IV)PF02878(PGM_PMM_I)PF02879(PGM_PMM_II)PF02880(PGM_PMM_III) | 5 | GLY A 418GLY A 399ILE A 444VAL A 409ILE A 403 | None | 0.99A | 4q5mA-4mrqA:undetectable | 4q5mA-4mrqA:19.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4njv | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 5 | ARG A 8ALA A 28VAL A 32GLY A 49ILE A 84 | RIT A 500 (-3.2A)RIT A 500 (-3.6A)NoneRIT A 500 (-3.4A)RIT A 500 (-4.3A) | 0.40A | 4q5mA-4njvA:17.6 | 4q5mA-4njvA:43.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4njv | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | GLY A 27ASP A 29GLY A 49ILE A 50PRO A 81ILE A 84 | RIT A 500 (-3.9A)RIT A 500 (-3.2A)RIT A 500 (-3.4A)RIT A 500 (-4.3A)RIT A 500 (-3.9A)RIT A 500 (-4.3A) | 0.59A | 4q5mA-4njvA:17.6 | 4q5mA-4njvA:43.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4o9r | SMOOTHENEDHOMOLOG/SOLUBLECYTOCHROME B562CHIMERIC PROTEIN (Escherichiacoli;Homo sapiens) |
PF01534(Frizzled)PF07361(Cytochrom_B562) | 5 | ALA A 283GLY A 277ILE A 317GLY A 388ILE A 234 | None | 0.95A | 4q5mA-4o9rA:undetectable | 4q5mA-4o9rA:18.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qlj | BETA-GLUCOSIDASE 7 (Oryza sativa) |
PF00232(Glyco_hydro_1) | 5 | ILE A 122GLY A 22PRO A 463VAL A 452ILE A 451 | None | 0.96A | 4q5mA-4qljA:undetectable | 4q5mA-4qljA:17.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xfj | ARGININOSUCCINATESYNTHASE (Mycolicibacteriumthermoresistibile) |
PF00764(Arginosuc_synth) | 6 | ALA A 240VAL A 220GLY A 276ILE A 230GLY A 248VAL A 180 | None | 0.88A | 4q5mA-4xfjA:undetectable | 4q5mA-4xfjA:20.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5aew | BIPHENYL DIOXYGENASESUBUNIT ALPHA (Paraburkholderiaxenovorans) |
PF00355(Rieske)PF00848(Ring_hydroxyl_A) | 5 | ALA A 223VAL A 352GLY A 389ILE A 350ILE A 395 | None | 0.91A | 4q5mA-5aewA:undetectable | 4q5mA-5aewA:19.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5fnu | KELCH-LIKEECH-ASSOCIATEDPROTEIN 1 (Mus musculus) |
PF01344(Kelch_1) | 5 | GLY A 605GLY A 462GLY A 603VAL A 377ILE A 416 | NoneL6I A1615 ( 3.2A)L6I A1615 (-3.3A)NoneNone | 1.00A | 4q5mA-5fnuA:undetectable | 4q5mA-5fnuA:22.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hn4 | HOMOISOCITRATEDEHYDROGENASE (Thermococcuskodakarensis) |
PF00180(Iso_dh) | 5 | ALA A 26ILE A 319GLY A 282ILE A 285VAL A 31 | None | 0.99A | 4q5mA-5hn4A:undetectable | 4q5mA-5hn4A:21.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5lkm | DNA REPAIR PROTEINRADA (Streptococcuspneumoniae) |
PF13481(AAA_25)PF13541(ChlI) | 5 | ALA A 371GLY A 391ILE A 444ILE A 399VAL A 294 | None | 1.01A | 4q5mA-5lkmA:undetectable | 4q5mA-5lkmA:20.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5mlh | - (-) |
no annotation | 5 | VAL A 58GLY A 39ILE A 75GLY A 33ILE A 31 | NoneNoneNoneNAP A 404 (-3.1A)None | 0.97A | 4q5mA-5mlhA:undetectable | 4q5mA-5mlhA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ohx | CYSTATHIONINEBETA-SYNTHASE (Apis mellifera) |
no annotation | 5 | ARG A 225GLY A 213GLY A 224GLY A 217PRO A 333 | HEM A 701 (-4.0A)NoneNonePLP A 702 (-3.6A)PLP A 702 (-4.0A) | 0.93A | 4q5mA-5ohxA:undetectable | 4q5mA-5ohxA:17.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5t2z | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 5 | ARG A 8ALA A 28VAL A 32GLY A 49ILE A 84 | None | 0.39A | 4q5mA-5t2zA:17.5 | 4q5mA-5t2zA:40.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5t2z | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | GLY A 27ASP A 29GLY A 49ILE A 50PRO A 81ILE A 84 | None | 0.62A | 4q5mA-5t2zA:17.5 | 4q5mA-5t2zA:40.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5tv2 | ELONGATION FACTOR G (Vibriovulnificus) |
PF00009(GTP_EFTU)PF03144(GTP_EFTU_D2) | 5 | ALA A 382GLY A 385GLY A 329VAL A 389ILE A 322 | None | 0.87A | 4q5mA-5tv2A:undetectable | 4q5mA-5tv2A:18.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ucy | TUBULIN ALPHA CHAIN (Tetrahymenathermophila) |
PF00091(Tubulin)PF03953(Tubulin_C) | 5 | VAL A 74GLY A 13ILE A 75GLY A 17ILE A 7 | None | 0.88A | 4q5mA-5ucyA:undetectable | 4q5mA-5ucyA:17.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5w94 | MAU2 CHROMATIDCOHESION FACTORHOMOLOGSISTER CHROMATIDCOHESION PROTEIN 2 (Saccharomycescerevisiae) |
PF10345(Cohesin_load)no annotation | 5 | ALA B 17ILE B 14GLY B 12GLY A 589ILE A 588 | None | 1.01A | 4q5mA-5w94B:undetectable | 4q5mA-5w94B:22.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xdy | HEAT SHOCK PROTEINHTRA (Mycobacteriumtuberculosis) |
no annotation | 5 | ALA A 308GLY A 256ILE A 272ILE A 243VAL A 259 | None | 0.95A | 4q5mA-5xdyA:undetectable | 4q5mA-5xdyA:17.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xsx | CHITINASE (Thermococcuschitonophagus) |
no annotation | 5 | ARG A 499ASP A 487GLY A 484ILE A 483ILE A 700 | GOL A1004 (-4.0A)GOL A1004 (-3.5A)NoneNoneNone | 0.92A | 4q5mA-5xsxA:undetectable | 4q5mA-5xsxA:16.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5z11 | CD8 ALPHA CHAIN (Ctenopharyngodonidella) |
no annotation | 5 | VAL A 19ILE A 76ASP A 43GLY A 86ILE A 106 | None | 1.01A | 4q5mA-5z11A:undetectable | 4q5mA-5z11A:20.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6cip | PYRUVATE-FERREDOXINOXIDOREDUCTASE (Moorellathermoacetica) |
no annotation | 5 | ALA A 575VAL A 569ILE A 570GLY A 439ILE A 438 | None | 1.00A | 4q5mA-6cipA:undetectable | 4q5mA-6cipA:17.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6fmq | - (-) |
no annotation | 5 | GLY A 605GLY A 462GLY A 603VAL A 377ILE A 416 | NoneNoneACT A 705 ( 3.8A)NoneNone | 1.01A | 4q5mA-6fmqA:undetectable | 4q5mA-6fmqA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6upj | HIV-2 PROTEASE (Humanimmunodeficiencyvirus 2) |
PF00077(RVP) | 5 | GLY A 27ASP A 29GLY A 49ILE A 50PRO A 81 | NIU A 100 (-4.5A)NoneNIU A 100 ( 3.8A)NIU A 100 (-3.9A)None | 0.84A | 4q5mA-6upjA:15.3 | 4q5mA-6upjA:26.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6upj | HIV-2 PROTEASE (Humanimmunodeficiencyvirus 2) |
PF00077(RVP) | 5 | GLY A 27ASP A 29GLY A 49PRO A 81ILE A 84 | NIU A 100 (-4.5A)NoneNIU A 100 ( 3.8A)NoneNone | 0.75A | 4q5mA-6upjA:15.3 | 4q5mA-6upjA:26.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1am5 | PEPSIN (Gadus morhua) |
PF00026(Asp) | 3 | ASP A 215ASP A 32ASN A 37 | None | 0.58A | 4q5mA-1am5A:9.3 | 4q5mA-1am5A:21.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1b2h | PERIPLASMICOLIGOPEPTIDE-BINDINGPROTEIN (Salmonellaenterica) |
PF00496(SBP_bac_5) | 3 | ASP A 122ASP A 433ASN A 436 | None | 0.78A | 4q5mA-1b2hA:undetectable | 4q5mA-1b2hA:16.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1g0v | PROTEINASE A (Saccharomycescerevisiae) |
PF00026(Asp) | 3 | ASP A 215ASP A 32ASN A 37 | None | 0.66A | 4q5mA-1g0vA:9.4 | 4q5mA-1g0vA:23.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1htr | GASTRICSIN (Homo sapiens) |
PF00026(Asp) | 3 | ASP B 217ASP B 32ASN B 37 | None | 0.60A | 4q5mA-1htrB:8.3 | 4q5mA-1htrB:23.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1i74 | PROBABLEMANGANESE-DEPENDENTINORGANICPYROPHOSPHATASE (Streptococcusmutans) |
PF01368(DHH)PF02833(DHHA2) | 3 | ASP A 149ASP A 75ASN A 77 | MN A 402 ( 2.6A) MN A 401 (-2.5A)None | 0.84A | 4q5mA-1i74A:undetectable | 4q5mA-1i74A:20.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1nrw | HYPOTHETICALPROTEIN, HALOACIDDEHALOGENASE-LIKEHYDROLASE (Bacillussubtilis) |
PF08282(Hydrolase_3) | 3 | ASP A 237ASP A 7ASN A 65 | CA A 903 (-2.9A)PO4 A 900 ( 2.6A)None | 0.82A | 4q5mA-1nrwA:undetectable | 4q5mA-1nrwA:21.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1o4z | BETA-AGARASE B (Zobelliagalactanivorans) |
PF00722(Glyco_hydro_16) | 3 | ASP A 102ASP A 103ASN A 92 | None | 0.81A | 4q5mA-1o4zA:undetectable | 4q5mA-1o4zA:19.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1p8r | ARGINASE 1 (Rattusnorvegicus) |
PF00491(Arginase) | 3 | ASP A 124ASP A 128ASN A 139 | MN A 500 (-2.6A) MN A 501 ( 2.6A)None | 0.81A | 4q5mA-1p8rA:undetectable | 4q5mA-1p8rA:22.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1q0p | COMPLEMENT FACTOR B (Homo sapiens) |
PF00092(VWA) | 3 | ASP A 364ASP A 251ASN A 329 | MN A 500 ( 4.0A) MN A 500 ( 4.0A)None | 0.66A | 4q5mA-1q0pA:undetectable | 4q5mA-1q0pA:20.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1qdm | PROPHYTEPSIN (Hordeum vulgare) |
PF00026(Asp)PF03489(SapB_2)PF05184(SapB_1) | 3 | ASP A 223ASP A 36ASN A 41 | None | 0.59A | 4q5mA-1qdmA:9.3 | 4q5mA-1qdmA:19.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1qrp | PEPSIN 3A (Homo sapiens) |
PF00026(Asp) | 3 | ASP E 215ASP E 32ASN E 37 | HH0 E 327 (-2.5A)HH0 E 327 (-2.7A)None | 0.52A | 4q5mA-1qrpE:10.2 | 4q5mA-1qrpE:24.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1qs8 | PLASMEPSIN (Plasmodiumvivax) |
PF00026(Asp) | 3 | ASP A 214ASP A 34ASN A 39 | None | 0.53A | 4q5mA-1qs8A:9.9 | 4q5mA-1qs8A:22.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1rtk | COMPLEMENT FACTOR B (Homo sapiens) |
PF00089(Trypsin)PF00092(VWA) | 3 | ASP A 364ASP A 251ASN A 329 | MG A 749 ( 4.4A) MG A 749 ( 4.3A)None | 0.66A | 4q5mA-1rtkA:undetectable | 4q5mA-1rtkA:15.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1smr | RENIN (Mus musculus) |
PF00026(Asp) | 3 | ASP A 215ASP A 32ASN A 37 | None | 0.71A | 4q5mA-1smrA:5.3 | 4q5mA-1smrA:22.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1t0p | INTEGRIN ALPHA-L (Homo sapiens) |
PF00092(VWA) | 3 | ASP A 239ASP A 137ASN A 207 | MG A 901 ( 3.9A) MG A 901 ( 4.0A)None | 0.83A | 4q5mA-1t0pA:undetectable | 4q5mA-1t0pA:19.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1toz | NEUROGENIC LOCUSNOTCH HOMOLOGPROTEIN 1 (Homo sapiens) |
PF00008(EGF)PF07645(EGF_CA) | 3 | ASP A 452ASP A 469ASN A 459 | None | 0.56A | 4q5mA-1tozA:undetectable | 4q5mA-1tozA:19.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1tzs | CATHEPSIN E (Homo sapiens) |
PF00026(Asp) | 3 | ASP A 228ASP A 43ASN A 48 | None | 0.61A | 4q5mA-1tzsA:10.0 | 4q5mA-1tzsA:22.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1wkr | POLYPOROPEPSIN (Irpex lacteus) |
PF00026(Asp) | 3 | ASP A 212ASP A 32ASN A 37 | None | 0.55A | 4q5mA-1wkrA:9.8 | 4q5mA-1wkrA:20.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1y75 | PHOSPHOLIPASE A2ISOFORM 5PHOSPHOLIPASE A2ISOFORM 6 (Najasagittifera) |
PF00068(Phospholip_A2_1) | 3 | ASP A 24ASP B 24ASN B 110 | ZN A 401 (-2.1A) ZN A 401 (-2.1A)None | 0.56A | 4q5mA-1y75A:undetectable | 4q5mA-1y75A:19.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1y75 | PHOSPHOLIPASE A2ISOFORM 5PHOSPHOLIPASE A2ISOFORM 6 (Najasagittifera) |
PF00068(Phospholip_A2_1) | 3 | ASP B 24ASP A 24ASN A 110 | ZN A 401 (-2.1A) ZN A 401 (-2.1A)None | 0.60A | 4q5mA-1y75B:undetectable | 4q5mA-1y75B:16.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2anl | PLASMEPSIN IV (Plasmodiummalariae) |
PF00026(Asp) | 3 | ASP A 214ASP A 34ASN A 39 | JE2 A3151 (-2.5A)JE2 A3151 (-3.0A)None | 0.65A | 4q5mA-2anlA:9.6 | 4q5mA-2anlA:22.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2bju | PLASMEPSIN II (Plasmodiumfalciparum) |
PF00026(Asp) | 3 | ASP A 214ASP A 34ASN A 39 | IH4 A1330 (-3.3A)IH4 A1330 (-4.2A)None | 0.84A | 4q5mA-2bjuA:8.9 | 4q5mA-2bjuA:18.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2bws | XAA-PROAMINOPEPTIDASE P (Escherichiacoli) |
PF00557(Peptidase_M24)PF05195(AMP_N) | 3 | ASP A 271ASP A 260ASN A 230 | MN A1442 ( 2.4A) MN A1442 (-2.0A)None | 0.84A | 4q5mA-2bwsA:undetectable | 4q5mA-2bwsA:19.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2cev | PROTEIN (ARGINASE) ([Bacillus]caldovelox) |
PF00491(Arginase) | 3 | ASP A 122ASP A 126ASN A 137 | MN A 302 (-2.5A) MN A 301 ( 2.6A)None | 0.74A | 4q5mA-2cevA:undetectable | 4q5mA-2cevA:23.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2dg0 | DRP35 (Staphylococcusaureus) |
PF08450(SGL) | 3 | ASP A 236ASP A 138ASN A 88 | None | 0.79A | 4q5mA-2dg0A:undetectable | 4q5mA-2dg0A:22.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ef4 | ARGINASE (Thermusthermophilus) |
PF00491(Arginase) | 3 | ASP A 119ASP A 123ASN A 134 | None | 0.76A | 4q5mA-2ef4A:undetectable | 4q5mA-2ef4A:20.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ewy | BETA-SECRETASE 2 (Homo sapiens) |
PF00026(Asp) | 3 | ASP A 241ASP A 48ASN A 53 | DBO A1001 (-3.2A)DBO A1001 (-2.7A)None | 0.61A | 4q5mA-2ewyA:9.2 | 4q5mA-2ewyA:23.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g1s | RENIN (Homo sapiens) |
PF00026(Asp) | 3 | ASP A 221ASP A 33ASN A 38 | 4IG A 885 (-2.6A)4IG A 885 (-2.7A)None | 0.60A | 4q5mA-2g1sA:10.6 | 4q5mA-2g1sA:22.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2i34 | ACID PHOSPHATASE (Bacillusanthracis) |
PF03767(Acid_phosphat_B) | 3 | ASP A 184ASP A 180ASN A 73 | MG A 301 ( 4.2A) MG A 301 (-2.5A)None | 0.71A | 4q5mA-2i34A:undetectable | 4q5mA-2i34A:20.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2l1w | CALMODULIN (Glycine max) |
PF13499(EF-hand_7) | 3 | ASP A 95ASP A 93ASN A 137 | CA A 221 (-2.3A) CA A 221 (-3.5A) CA A 234 (-3.6A) | 0.83A | 4q5mA-2l1wA:undetectable | 4q5mA-2l1wA:21.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2mte | CELLULOSE1,4-BETA-CELLOBIOSIDASE (REDUCING END)CELS (Ruminiclostridiumthermocellum) |
PF00404(Dockerin_1) | 3 | ASP A 43ASP A 50ASN A 37 | CA A 102 (-2.1A) CA A 102 (-1.9A)None | 0.60A | 4q5mA-2mteA:undetectable | 4q5mA-2mteA:17.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2odp | COMPLEMENT C2 (Homo sapiens) |
PF00089(Trypsin)PF00092(VWA) | 3 | ASP A 356ASP A 240ASN A 318 | MG A 901 ( 4.0A) MG A 901 ( 3.9A)None | 0.72A | 4q5mA-2odpA:undetectable | 4q5mA-2odpA:18.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2rhp | THROMBOSPONDIN-2 (Homo sapiens) |
PF02412(TSP_3)PF05735(TSP_C)PF07645(EGF_CA)PF12947(EGF_3) | 3 | ASP A 718ASP A 696ASN A1017 | CA A 29 ( 2.3A) CA A 28 ( 2.6A)None | 0.70A | 4q5mA-2rhpA:undetectable | 4q5mA-2rhpA:15.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vdw | VACCINIA VIRUSCAPPING ENZYME D1SUBUNIT (Vaccinia virus) |
PF03291(Pox_MCEL) | 3 | ASP A 676ASP A 604ASN A 601 | SAH A1846 ( 4.7A)SAH A1846 ( 4.5A)SO4 A1845 (-4.1A) | 0.83A | 4q5mA-2vdwA:undetectable | 4q5mA-2vdwA:21.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2we9 | MOBA-RELATED PROTEIN (Mycobacteriumtuberculosis) |
PF12804(NTP_transf_3) | 3 | ASP A 105ASP A 183ASN A 17 | GOL A1196 (-3.4A)NoneNone | 0.84A | 4q5mA-2we9A:undetectable | 4q5mA-2we9A:23.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xwb | COMPLEMENT FACTOR B (Homo sapiens) |
PF00084(Sushi)PF00089(Trypsin)PF00092(VWA) | 3 | ASP F 364ASP F 251ASN F 329 | MG F1742 ( 4.2A) MG F1742 ( 4.5A)None | 0.83A | 4q5mA-2xwbF:undetectable | 4q5mA-2xwbF:13.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ak5 | HEMOGLOBIN-BINDINGPROTEASE HBP (Escherichiacoli) |
PF02395(Peptidase_S6) | 3 | ASP A 744ASP A 639ASN A 717 | None | 0.85A | 4q5mA-3ak5A:undetectable | 4q5mA-3ak5A:12.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bij | UNCHARACTERIZEDPROTEIN GSU0716 (Geobactersulfurreducens) |
PF00656(Peptidase_C14) | 3 | ASP A 133ASP A 32ASN A 27 | None | 0.84A | 4q5mA-3bijA:undetectable | 4q5mA-3bijA:20.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3et5 | OUTER MEMBRANEPROTEIN P4, NADPPHOSPHATASE (Haemophilusinfluenzae) |
PF03767(Acid_phosphat_B) | 3 | ASP A 185ASP A 181ASN A 72 | MG A 255 ( 4.2A) MG A 255 (-2.6A)None | 0.73A | 4q5mA-3et5A:undetectable | 4q5mA-3et5A:20.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ewe | NUCLEOPORIN NUP85 (Saccharomycescerevisiae) |
PF07575(Nucleopor_Nup85) | 3 | ASP B 330ASP B 334ASN B 342 | None | 0.79A | 4q5mA-3eweB:undetectable | 4q5mA-3eweB:17.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3fby | CARTILAGE OLIGOMERICMATRIX PROTEIN (Homo sapiens) |
PF02412(TSP_3)PF05735(TSP_C) | 3 | ASP A 290ASP A 271ASN A 589 | CA A 802 ( 2.3A) CA A 801 ( 2.8A)None | 0.75A | 4q5mA-3fbyA:undetectable | 4q5mA-3fbyA:15.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hig | AMILORIDE-SENSITIVEAMINE OXIDASE (Homo sapiens) |
PF01179(Cu_amine_oxid)PF02727(Cu_amine_oxidN2)PF02728(Cu_amine_oxidN3) | 3 | ASP A 664ASP A 519ASN A 338 | CA A 802 (-3.2A) CA A 802 (-3.2A)None | 0.56A | 4q5mA-3higA:undetectable | 4q5mA-3higA:13.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3igz | COFACTOR-INDEPENDENTPHOSPHOGLYCERATEMUTASE (Leishmaniamexicana) |
PF01676(Metalloenzyme)PF06415(iPGM_N) | 3 | ASP B 23ASP B 466ASN B 80 | CO B 563 ( 2.2A) CO B 563 (-2.4A)None | 0.80A | 4q5mA-3igzB:undetectable | 4q5mA-3igzB:17.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3jte | RESPONSE REGULATORRECEIVER PROTEIN (Ruminiclostridiumthermocellum) |
PF00072(Response_reg) | 3 | ASP A 11ASP A 10ASN A 18 | None | 0.85A | 4q5mA-3jteA:undetectable | 4q5mA-3jteA:23.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3nvl | 2,3-BISPHOSPHOGLYCERATE-INDEPENDENTPHOSPHOGLYCERATEMUTASE (Trypanosomabrucei) |
PF01676(Metalloenzyme)PF06415(iPGM_N) | 3 | ASP A 22ASP A 465ASN A 79 | CO A 553 (-2.1A) CO A 553 (-2.3A)None | 0.76A | 4q5mA-3nvlA:undetectable | 4q5mA-3nvlA:17.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3pct | CLASS C ACIDPHOSPHATASE (Pasteurellamultocida) |
PF03767(Acid_phosphat_B) | 3 | ASP A 184ASP A 180ASN A 71 | None | 0.71A | 4q5mA-3pctA:undetectable | 4q5mA-3pctA:18.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3psg | PEPSINOGEN (Sus scrofa) |
PF00026(Asp)PF07966(A1_Propeptide) | 3 | ASP A 215ASP A 32ASN A 37 | None | 0.68A | 4q5mA-3psgA:8.5 | 4q5mA-3psgA:20.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3q2w | CADHERIN-2 (Mus musculus) |
PF00028(Cadherin) | 3 | ASP A 331ASP A 366ASN A 335 | CA A 608 (-3.2A) CA A 608 ( 3.4A)None | 0.75A | 4q5mA-3q2wA:undetectable | 4q5mA-3q2wA:18.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3q5i | PROTEIN KINASE (Plasmodiumberghei) |
PF00069(Pkinase)PF13499(EF-hand_7) | 3 | ASP A 502ASP A 498ASN A 491 | CA A 526 (-2.9A) CA A 526 (-3.1A)None | 0.82A | 4q5mA-3q5iA:undetectable | 4q5mA-3q5iA:17.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qc5 | PLATELET BINDINGPROTEIN GSPB (Streptococcusgordonii) |
no annotation | 3 | ASP X 399ASP X 427ASN X 496 | K X 1 (-2.1A) K X 1 ( 2.0A)None | 0.82A | 4q5mA-3qc5X:undetectable | 4q5mA-3qc5X:19.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qs1 | PLASMEPSIN-1 (Plasmodiumfalciparum) |
PF00026(Asp) | 3 | ASP A 215ASP A 32ASN A 37 | 006 A 330 (-2.8A)006 A 330 (-2.8A)None | 0.71A | 4q5mA-3qs1A:10.0 | 4q5mA-3qs1A:22.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3sl1 | ARGINASE (Plasmodiumfalciparum) |
PF00491(Arginase) | 3 | ASP A 216ASP A 220ASN A 231 | MN A 413 (-2.6A)FB6 A 414 ( 2.6A)None | 0.83A | 4q5mA-3sl1A:undetectable | 4q5mA-3sl1A:17.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ti7 | BASIC EXTRACELLULARSUBTILISIN-LIKEPROTEASE BPRV (Dichelobacternodosus) |
PF00082(Peptidase_S8) | 3 | ASP A 74ASP A 69ASN A 66 | CA A 354 ( 2.4A) CA A 355 ( 2.3A)None | 0.83A | 4q5mA-3ti7A:undetectable | 4q5mA-3ti7A:21.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3w57 | C2 DOMAIN PROTEIN (Scophthalmusmaximus) |
PF00168(C2) | 3 | ASP A 35ASP A 88ASN A 59 | CA A 201 ( 2.9A) CA A 201 ( 2.3A)None | 0.85A | 4q5mA-3w57A:undetectable | 4q5mA-3w57A:21.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4amt | RENIN (Homo sapiens) |
PF00026(Asp)PF07966(A1_Propeptide) | 3 | ASP A 269ASP A 81ASN A 86 | None | 0.59A | 4q5mA-4amtA:6.6 | 4q5mA-4amtA:20.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4cyf | PANTETHEINASE (Homo sapiens) |
PF00795(CN_hydrolase) | 3 | ASP A 98ASP A 141ASN A 189 | None | 0.71A | 4q5mA-4cyfA:undetectable | 4q5mA-4cyfA:17.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4dh2 | CELLULOSOMEANCHORING PROTEINCOHESIN REGIONDOCKERIN TYPE 1 (Ruminiclostridiumthermocellum) |
PF00404(Dockerin_1)PF00963(Cohesin) | 3 | ASP B 9ASP B 20ASN A 140 | CA B 101 (-3.3A) CA B 101 (-2.1A)None | 0.74A | 4q5mA-4dh2B:undetectable | 4q5mA-4dh2B:18.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4dni | FUSION PROTEIN OFRNA-EDITING COMPLEXPROTEINS MP42 ANDMP18 (Trypanosomabrucei) |
PF00436(SSB) | 3 | ASP A 82ASP A 84ASN A 161 | None | 0.77A | 4q5mA-4dniA:undetectable | 4q5mA-4dniA:19.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ehc | PE-PGRS FAMILYPROTEIN (Mycobacteriumtuberculosis) |
no annotation | 3 | ASP A 36ASP A 189ASN A 194 | ZN A 301 (-2.3A) ZN A 301 (-2.0A)EDO A 320 (-3.1A) | 0.79A | 4q5mA-4ehcA:11.2 | 4q5mA-4ehcA:22.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4g9i | HYDROGENASEMATURATION PROTEINHYPF (Thermococcuskodakarensis) |
PF00708(Acylphosphatase)PF00814(Peptidase_M22)PF01300(Sua5_yciO_yrdC)PF07503(zf-HYPF) | 3 | ASP A 509ASP A 746ASN A 427 | ZN A1003 (-2.2A) ZN A1003 (-2.4A)None | 0.74A | 4q5mA-4g9iA:undetectable | 4q5mA-4g9iA:13.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4h3w | HYPOTHETICAL PROTEIN (Parabacteroidesdistasonis) |
PF15414(DUF4621) | 3 | ASP A 90ASP A 200ASN A 206 | MLY A 91 ( 4.2A)MLY A 202 ( 4.0A)MLY A 202 ( 3.4A) | 0.77A | 4q5mA-4h3wA:undetectable | 4q5mA-4h3wA:18.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hxq | ARGINASE-1 (Homo sapiens) |
PF00491(Arginase) | 3 | ASP A 124ASP A 128ASN A 139 | MN A 903 (-2.5A) MN A 903 ( 2.6A)None | 0.75A | 4q5mA-4hxqA:undetectable | 4q5mA-4hxqA:24.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4iu4 | ARGINASE (Leishmaniamexicana) |
PF00491(Arginase) | 3 | ASP A 137ASP A 141ASN A 152 | MN A 401 (-2.6A) MN A 401 ( 2.5A)None | 0.75A | 4q5mA-4iu4A:undetectable | 4q5mA-4iu4A:22.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ixu | ARGINASE-2,MITOCHONDRIAL (Homo sapiens) |
PF00491(Arginase) | 3 | ASP A 143ASP A 147ASN A 158 | MN A 401 (-2.5A)38I A 406 ( 2.5A)None | 0.82A | 4q5mA-4ixuA:undetectable | 4q5mA-4ixuA:19.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4jo0 | CMLA (Streptomycesvenezuelae) |
PF12706(Lactamase_B_2) | 3 | ASP A 309ASP A 403ASN A 459 | FE A 602 (-2.2A) FE A 602 ( 2.6A)None | 0.81A | 4q5mA-4jo0A:undetectable | 4q5mA-4jo0A:16.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4pv4 | PROLINEAMINOPEPTIDASE P II (Yersinia pestis) |
PF00557(Peptidase_M24)PF05195(AMP_N) | 3 | ASP A 269ASP A 258ASN A 228 | MG A 501 ( 2.5A) MG A 501 ( 2.0A)None | 0.80A | 4q5mA-4pv4A:undetectable | 4q5mA-4pv4A:19.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4q3r | ARGINASE (Schistosomamansoni) |
PF00491(Arginase) | 3 | ASP A 154ASP A 158ASN A 169 | MN A 401 (-2.6A) MN A 401 ( 2.5A)None | 0.76A | 4q5mA-4q3rA:undetectable | 4q5mA-4q3rA:22.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4rcd | BETA-SECRETASE 1 (Homo sapiens) |
PF00026(Asp) | 3 | ASP A 32ASP A 228ASN A 233 | 3LL A 501 (-2.8A)3LL A 501 (-2.6A)None | 0.57A | 4q5mA-4rcdA:9.3 | 4q5mA-4rcdA:19.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4rcd | BETA-SECRETASE 1 (Homo sapiens) |
PF00026(Asp) | 3 | ASP A 228ASP A 32ASN A 37 | 3LL A 501 (-2.6A)3LL A 501 (-2.8A)None | 0.62A | 4q5mA-4rcdA:9.3 | 4q5mA-4rcdA:19.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4rn7 | N-ACETYLMURAMOYL-L-ALANINE AMIDASE (Clostridioidesdifficile) |
PF01520(Amidase_3) | 3 | ASP A 143ASP A 171ASN A 128 | None | 0.75A | 4q5mA-4rn7A:undetectable | 4q5mA-4rn7A:20.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4rpa | PROBABLEMANGANESE-DEPENDENTINORGANICPYROPHOSPHATASE (Staphylococcusaureus) |
PF01368(DHH)PF02833(DHHA2) | 3 | ASP A 149ASP A 75ASN A 77 | MN A 500 (-2.6A) MN A 500 ( 2.4A)None | 0.82A | 4q5mA-4rpaA:undetectable | 4q5mA-4rpaA:18.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4uaq | PROTEIN TRANSLOCASESUBUNIT SECA 2 (Mycobacteriumtuberculosis) |
PF01043(SecA_PP_bind)PF07516(SecA_SW)PF07517(SecA_DEAD) | 3 | ASP A 224ASP A 219ASN A 540 | None | 0.80A | 4q5mA-4uaqA:undetectable | 4q5mA-4uaqA:13.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xj5 | CYCLIC AMP-GMPSYNTHASE (Vibrio cholerae) |
no annotation | 3 | ASP A 133ASP A 131ASN A 121 | MG A1001 ( 2.7A) MG A1002 (-2.0A)None | 0.84A | 4q5mA-4xj5A:undetectable | 4q5mA-4xj5A:19.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xj6 | VC0179-LIKE PROTEIN (Escherichiacoli) |
no annotation | 3 | ASP A 131ASP A 129ASN A 119 | MG A 501 ( 2.5A) MG A 502 (-2.2A)None | 0.72A | 4q5mA-4xj6A:undetectable | 4q5mA-4xj6A:16.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xru | PNKP1 (Capnocytophagagingivalis) |
PF13671(AAA_33) | 3 | ASP A 288ASP A 287ASN A 265 | MG A 401 (-2.2A) MG A 401 ( 4.8A)None | 0.80A | 4q5mA-4xruA:undetectable | 4q5mA-4xruA:19.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4yg8 | CHITIN BIOSYNTHESISPROTEIN CHS6 (Saccharomycescerevisiae) |
PF09295(ChAPs) | 3 | ASP B 588ASP B 592ASN B 510 | None | 0.76A | 4q5mA-4yg8B:undetectable | 4q5mA-4yg8B:14.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4zng | PROLIDASE (Lactococcuslactis) |
no annotation | 3 | ASP C 221ASP C 232ASN C 324 | MN C 401 (-2.2A) MN C 401 (-2.2A)None | 0.83A | 4q5mA-4zngC:undetectable | 4q5mA-4zngC:19.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5cde | PROLINE DIPEPTIDASE (Xanthomonascampestris) |
PF00557(Peptidase_M24)PF01321(Creatinase_N) | 3 | ASP A 251ASP A 262ASN A 359 | ZN A 402 (-2.0A) ZN A 402 ( 2.3A)None | 0.82A | 4q5mA-5cdeA:undetectable | 4q5mA-5cdeA:21.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5eyy | CENTROLOBIUMTOMENTOSUM LECTIN (Centrolobiumtomentosum) |
PF00139(Lectin_legB) | 3 | ASP A 131ASP A 142ASN A 137 | CA A 302 ( 2.1A) MN A 303 ( 2.7A)MDM A 304 (-2.9A) | 0.83A | 4q5mA-5eyyA:undetectable | 4q5mA-5eyyA:18.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5foe | GDP-FUCOSE PROTEINO-FUCOSYLTRANSFERASE2,THROMBOSPONDIN-1 (Caenorhabditiselegans;Homo sapiens) |
PF00090(TSP_1)PF10250(O-FucT) | 3 | ASP A 259ASP A 248ASN A 241 | None | 0.54A | 4q5mA-5foeA:undetectable | 4q5mA-5foeA:17.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5fqe | BETA-N-ACETYLGALACTOSAMINIDASE (Clostridiumperfringens) |
PF13320(DUF4091) | 3 | ASP A 42ASP A 512ASN A 570 | NoneNone BR A1632 (-4.8A) | 0.85A | 4q5mA-5fqeA:undetectable | 4q5mA-5fqeA:15.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hj2 | INTEGRIN ALPHA-2 (Homo sapiens) |
no annotation | 3 | ASP C 118ASP C 15ASN C 86 | CA C 301 (-3.4A) CA C 301 ( 4.5A)None | 0.74A | 4q5mA-5hj2C:undetectable | 4q5mA-5hj2C:22.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5i70 | PLASMEPSIN IV (Plasmodiumfalciparum) |
no annotation | 3 | ASP B 214ASP B 34ASN B 39 | None | 0.47A | 4q5mA-5i70B:10.1 | 4q5mA-5i70B:18.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jqk | PEPTIDASE, PUTATIVE (Plasmodiumfalciparum) |
PF00557(Peptidase_M24)PF01321(Creatinase_N)PF16188(Peptidase_M24_C)PF16189(Creatinase_N_2) | 3 | ASP A 570ASP A 581ASN A 675 | MN A 802 ( 1.9A) MN A 802 (-2.2A)None | 0.69A | 4q5mA-5jqkA:undetectable | 4q5mA-5jqkA:15.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ksd | ATPASE 2, PLASMAMEMBRANE-TYPE (Arabidopsisthaliana) |
PF00122(E1-E2_ATPase)PF00690(Cation_ATPase_N)PF00702(Hydrolase) | 3 | ASP A 275ASP A 92ASN A 85 | None | 0.74A | 4q5mA-5ksdA:undetectable | 4q5mA-5ksdA:14.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5mkt | RENIN-1 (Mus musculus) |
no annotation | 3 | ASP A 266ASP A 81ASN A 86 | None | 0.80A | 4q5mA-5mktA:9.1 | 4q5mA-5mktA:19.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5mlg | RENIN (Rattusnorvegicus) |
no annotation | 3 | ASP A 266ASP A 81ASN A 86 | None | 0.66A | 4q5mA-5mlgA:9.9 | 4q5mA-5mlgA:18.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5n7q | PUTATIVE CATHEPSIN D (Ixodes ricinus) |
no annotation | 3 | ASP A 227ASP A 36ASN A 41 | None | 0.55A | 4q5mA-5n7qA:10.0 | 4q5mA-5n7qA:17.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5pep | PEPSIN (Sus scrofa) |
PF00026(Asp) | 3 | ASP A 215ASP A 32ASN A 37 | None | 0.51A | 4q5mA-5pepA:9.7 | 4q5mA-5pepA:20.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5t4m | PROTOCADHERIN-15 (Homo sapiens) |
PF00028(Cadherin) | 3 | ASP A 516ASP A 514ASN A 575 | CA A 704 ( 3.3A) CA A 705 (-2.1A)None | 0.84A | 4q5mA-5t4mA:undetectable | 4q5mA-5t4mA:21.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5u1c | HIV-1 INTEGRASE,SSO7D CHIMERA (Humanimmunodeficiencyvirus 1;Sulfolobussolfataricus) |
PF00552(IN_DBD_C)PF00665(rve)PF02022(Integrase_Zn) | 3 | ASP A 64ASP A 116ASN A 144 | MG A 501 (-1.8A) MG A 501 (-2.8A)None | 0.68A | 4q5mA-5u1cA:undetectable | 4q5mA-5u1cA:21.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5udy | ECTONUCLEOTIDEPYROPHOSPHATASE/PHOSPHODIESTERASE FAMILYMEMBER 7 (Homo sapiens) |
PF01663(Phosphodiest) | 3 | ASP A 187ASP A 189ASN A 31 | None | 0.68A | 4q5mA-5udyA:undetectable | 4q5mA-5udyA:18.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ux4 | CATHEPSIN D (Rattusnorvegicus) |
no annotation | 3 | ASP A 226ASP A 33ASN A 38 | 3UT A 404 (-2.4A)3UT A 404 (-2.9A)None | 0.57A | 4q5mA-5ux4A:9.9 | 4q5mA-5ux4A:16.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5v8f | ORIGIN RECOGNITIONCOMPLEX SUBUNIT 2ORIGIN RECOGNITIONCOMPLEX SUBUNIT 3ORIGIN RECOGNITIONCOMPLEX SUBUNIT 5 (Saccharomycescerevisiae) |
PF04084(ORC2)PF13401(AAA_22)PF14630(ORC5_C)no annotation | 3 | ASP C 111ASP B 466ASN E 423 | None | 0.65A | 4q5mA-5v8fC:undetectable | 4q5mA-5v8fC:16.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wkh | T-CELL RECEPTORALPHA VARIABLE30,T-CELL RECEPTOR,SP3.4 ALPHA CHAIN (Homo sapiens) |
PF07686(V-set)PF09291(DUF1968) | 3 | ASP D 163ASP D 161ASN D 197 | None | 0.73A | 4q5mA-5wkhD:undetectable | 4q5mA-5wkhD:18.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wtl | OMPA FAMILY PROTEIN (Capnocytophagagingivalis) |
no annotation | 3 | ASP A 281ASP A 283ASN A 301 | CA A1008 ( 2.8A) CA A1007 ( 2.7A)None | 0.77A | 4q5mA-5wtlA:undetectable | 4q5mA-5wtlA:15.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wtl | OMPA FAMILY PROTEIN (Capnocytophagagingivalis) |
no annotation | 3 | ASP A 310ASP A 312ASN A 330 | CA A1009 ( 2.8A) CA A1009 ( 2.7A)None | 0.69A | 4q5mA-5wtlA:undetectable | 4q5mA-5wtlA:15.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6bm8 | ENVELOPEGLYCOPROTEIN B (Humanalphaherpesvirus1) |
no annotation | 3 | ASP A 608ASP A 579ASN A 112 | None | 0.76A | 4q5mA-6bm8A:undetectable | 4q5mA-6bm8A:16.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6ej2 | BETA-SECRETASE 1 (Homo sapiens) |
no annotation | 3 | ASP A 441ASP A 637ASN A 642 | B7E A 901 (-2.9A)B7E A 901 (-2.6A)None | 0.63A | 4q5mA-6ej2A:9.1 | 4q5mA-6ej2A:21.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6ej2 | BETA-SECRETASE 1 (Homo sapiens) |
no annotation | 3 | ASP A 637ASP A 441ASN A 446 | B7E A 901 (-2.6A)B7E A 901 (-2.9A)B7E A 901 (-4.2A) | 0.50A | 4q5mA-6ej2A:9.1 | 4q5mA-6ej2A:21.20 |